Právní předpis byl sestaven k datu 27.01.2025.
Zobrazené znění právního předpisu je účinné od 22.08.2023 do 27.01.2025.
32
XXXXXXX
Xxxxxxxxxxxx xxxxxxxxxxxx xxxx, xxxxxx xx xxxx x doplňují xxxxxxx Xxxxxxxxxxxx zahraničních xxxx x. 58/2007 Sb. x. s. a x. 46/2008 Xx. x. x.
&xxxx;
Xxxxxxxxxxxx xxxxxxxxxxxx xxxx xxxxxxx, xx xxx 15. xxxxxxxxx 2022 xxxx generální xxxxxxxxxx XXXXXX xxxxxxxx xxxxxxxxx xxxxxx xxxxx Xxxxxxx X (Seznam xxxxxxxxxx xxxxx a xxxxx xxxxxxx xxx xxx 2023 - Xxxxxxxxxxx xxxxxxxx) x Xxxxxxx XX - Xxxxxxxxxxx standard xxx xxxxxxxxxxxx xxxxxxx pro xxx 2023 Xxxxxxxxxxx xxxxxx proti xxxxxxx xx xxxxxx1).
X xxxxx xxxxxx Přílohy X x Přílohy II xxxxxxxx souhlas Parlament Xxxxx xxxxxxxxx x xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxx o xxxxxxx xxxx Xxxxxxx X x Xxxxxxx II Xxxxxx republikou.
Nové znění Xxxxxxx X x Xxxxxxx II xxxxxxxxx x xxxxxxxx x xxxxxxx s článkem 34 xxxx. 3 Xxxxxx xxx 1. xxxxx 2023, xxx Českou xxxxxxxxx xxxxxxxxx x xxxxxxxx dne 22. xxxxxx 2023 x xxxxxxxxx
- Xxxxxxx I xxx xxx 20222), xxxxx xxxxxxxxx x xxxxxxxx xxx 1. xxxxx 2022 x xxx Xxxxxx republiku xxxxxxxxx v platnost xxx 27. xxxxx 2023, která nahradila Xxxxxxx I pro xxx 20183), xxxxxxx xx 1. ledna 2018, která vstoupila x xxxxxxxx xxx Xxxxxx republiku xxx 5. června 2019,
x
- Xxxxxxx XX xxx xxx 20164), která xxxxxxxxx v xxxxxxxx xxx 14. xxxxxx 2016 x pro Xxxxxx xxxxxxxxx vstoupila x platnost dne 24. dubna 2017.
Xxxxxxxx xxxxx Xxxxxxx I x Xxxxxxx XX xxx rok 2023 x xxxxxx xxxxxxx xx xxxxxxx xxxxxx xx xxxxxxxxx xxxxxxxx.
XXXXXXX
XXXXXXX XXXXXXXXXXXXX XXXXX
XXXXXXXXXXX XXXXXXXX
XXXXXX XXXXXXXXXX
XXXXX X XXXXX
2023
Xxxxx Xxxxxx xx xxxxxx xx 1.1.2023.
XXXXX
Xxxx xxxxxxx&xxxx;Xxxxxx&xxxx;xxxxxxxx xxxxxxxxxxx stavů xxxxxx xxx xxxxx.
|
XXXXX A XXXXXX XXXXXXXX XXXXXX |
|
|
X0 Xxxxxxxxxxx látky |
|
|
S1 Anabolické xxxxx |
|
|
Xxxxxxx x xxxxxx xxxxx xxx xxx xxxxxxx nalézt v xxxxxx xxxxxxxxxxx k xxxxx xxxx. xxxxxxxx xxxxxxxxxxxxx. |
|
|
X2 Xxxxxxxxx xxxxxxx, xxxxxxx xxxxxxx, xxxxxxxx xxxxx x xxxxxxxx |
|
|
Xxxxxxx x xxxxxx látek xxx xxx xxxxxxx xxxxxx x lécích xxxxxxxxxxx x xxxxx xxxx. xxxxxx, mužského xxxxxxxxxxxxx x xxxxxxxxxx xxxxxxxxx xxxxxxx. |
|
|
X3 Beta-2 xxxxxxxx |
|
|
Xxxxxxx z xxxxxx xxxxx xxx bez xxxxxxx xxxxxx x xxxxxx xxxxxxxxxxx x xxxxx např. xxxxxxx x jiných respiračních xxxxxx. |
|
|
X4 Xxxxxxxxx x xxxxxxxxxxx xxxxxxxxxx |
|
|
Xxxxxxx z xxxxxx látek lze xxx xxxxxxx xxxxxx x lécích xxxxxxxxxxx x léčbě xxxx. xxxxxxxx xxxx, cukrovky, xxxxxx xxxxxxxxxxx, xxxxxxxx xxxxxxxxxxxxxx vaječníků. |
|
|
S5 Diuretika x xxxxxxxxx xxxxx. |
|
|
Xxxxxxx x těchto látek xxx xxx xxxxxxx xxxxxx v xxxxxx xxxxxxxxxxx k xxxxx xxxx. xxxxxxxxx xxxxxxx, xxxxxxxxxx. |
|
|
X1–X2–X3 Zakázané xxxxxx |
|
|
XXXXX X METODY XXXXXXXX XXX SOUTĚŽI |
|
|
S6 Stimulancia |
|
|
Některé x xxxxxx xxxxx xxx bez xxxxxxx xxxxxx v xxxxxx xxxxxxxxxxx x xxxxx xxxx. xxxxxxxxx, xxxxxxx xxxxxxxxxx xxxxx x xxxxxxxxxxxxxx (ADHD), xxxxxxxx xxxxxxxxxx x xxxxxxx. |
|
|
X7 Xxxxxxxxx |
|
|
Xxxxxxx x xxxxxx xxxxx xxx xxx xxxxxxx xxxxxx v xxxxxx xxxxxxxxxxx k xxxxx xxxx. xxxxxxx xxxxxx xxxxxxxx pohybového xxxxxxx. |
|
|
X8 Xxxxxxxxxxx |
|
|
X9 Xxxxxxxxxxxxxxx |
|
|
Xxxxxxx x těchto xxxxx xxx bez xxxxxxx xxxxxx x xxxxxx xxxxxxxxxxx k léčbě xxxx. xxxxxxx, xxxxxxxxx, xxxxxxx, xxxxxxxxxxx xxxxxxxxxxxx xxxxx. |
|
|
XXXXX ZAKÁZANÉ X XXXXXXXXX XXXXXXXX |
|
|
X1 Xxxx-xxxxxxxxx |
|
|
Xxxxxxx x těchto xxxxx xxx xxx xxxxxxx xxxxxx v xxxxxx xxxxxxxxxxx x xxxxx xxxx. srdečního xxxxxxx, xxxxxxxxxx. |
|
|
XXXXXXXX |
|
XXXXXX XXXXXXXXXX LÁTEK X METOD XXXXXXX 2023
XXXXXXX XXXXXXXXXXXXX KODEX
ÚČINNÝ XX 1. XXXXX 2023
Xxxx
Xxxxxx&xxxx;xxxxxxxxxx xxxxx a xxxxx xxxxxxx (Seznam) xx xxxxxxx&xxxx;Xxxxxxxxxxx xxxxxxxx&xxxx;xxxx xxxxxxx xxxxxxxxx antidopingového xxxxxxxx.
Xxxxxx&xxxx;xx xxxxxxxxxxx xxxxxx xxxxx xx xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxxxxxxxxxxxxxxx&xxxx;XXXX. Xxxxx účinnosti Seznamu je 1. xxxxx 2023.
Xxxxxxxxx xxxxx&xxxx;Xxxxxxx&xxxx;xxxxxxxxxx xxxxx x metod xxxxxxx xx xxx xxxxxxx&xxxx;XXXX&xxxx;x xx xxxxxxxxxxx x xxxxxxxxx a xxxxxxxxxxxx xxxxxx. X xxxxxxx xxxxxxxxxxx konfliktu xxxx anglickou x xxxxxxxxxxxx verzí má xxxxxxxx xx xxxxxxxx.
Xxxx xxxx xxxxxxx xxxxxxx xxxxxxxx xxxxxxxxx x&xxxx;Xxxxxxx xxxxxxxxxx látek x xxxxx.
Xxxxxxxx Xxx Xxxxxxx
X xxxxxxxx xxxxxx xxxxxx, xxxxx by WADA schválila xxx xxxxxx sport, xx xxxxxx&xxxx;Xxx Xxxxxxx&xxxx;x xxxxxx xxxxxx xxxxxxxxxx xxxxx xxxx xxxxxxx (xx 23:59) den xxxx&xxxx;Xxxxxxx, xxxxx xx má Sportovec účastnit, xx xx konce Soutěže a xxxxxxx xxxxxx&xxxx;Xxxxxx.
Xxxxxxxx stále
Látka xxxx xxxxxx xx xxxxxxxx xxx&xxxx;Xxx Xxxxxxx, xxx x&xxxx;Xxxx Xxxxxx, xxx je xxxxxxxxxx x&xxxx;Xxxxxx.
Xxxxxxxxxx x xxxxxxxxxxxx
Xxxxx xxxxxx 4.2.2&xxxx;Xxxxxxxxx xxxxxxxxxxxxxxx Xxxxxx&xxxx;"Xxx účely xxxxxxxx xxxxxx 10 budou xxxxxxx&xxxx;Xxxxxxxx xxxxx&xxxx;Xxxxxxxxxxxx xxxxxxx, xxxxx xxxxx označených x&xxxx;Xxxxxxx. Žádná Zakázaná xxxxxx&xxxx;xxxxxx&xxxx;Xxxxxxxxxxx xxxxxxx, xxxxx xxxx x&xxxx;Xxxxxxx&xxxx;xxxxxxxxx xxxxxxxx xxxx&xxxx;Xxxxxxxxxx xxxxxx.". Xxxxx xxxxxxxxx x xxxxxx 4.2.2 xxxxx "Specifické xxxxx&xxxx;x&xxxx;xxxxxx&xxxx;xxxxxxx x xxxxxx 4.2.2 xxxxx xxxxxxx považovat xx xxxx xxxxxxxx xxxx xxxx xxxxxxxxxx xxx xxxx xxxxxxxxx xxxxx xx metody. Xxxxxxxxx jde spíše x xxxxx, xxxxx&xxxx;Xxxxxxxxx&xxxx;x xxxxx pravděpodobností xxxxxxx xx jiným xxxxxx xxx xxx zvýšení xxx xxxxxxxxx xxxxxxxxxx."
Xxxxxxxx xxxxx
Xxxxx xxxxxx 4.2.3&xxxx;Xxxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxx&xxxx;xxxxxxxxxx xxxx "Xxxxxxxx xxxxx, xxxxx xxxx x&xxxx;Xxxxxxx&xxxx;xxxxxxxxx xxxxxxxx xxxx&xxxx;Xxxxxxxx xxxxx&xxxx;x xxxxxx xxxxxx xxxxxxx xxxxxxxxxx ve xxxxxxxxxxx xxxx xxxxx xxxxxx". Následující xxxxx xxxx označovány xxxx&xxxx;Xxxxxxxx xxxxx: xxxxxx, xxxxxxxxx (xxxxxx), xxxxxxxxxxxxxxxxxxxxxxxx (MDMA/"extáze") x tetrahydrokanabinol (XXX).
X0 XXXXXXXXXXX XXXXX
XXXXXXXX STÁLE (XXX XXXXXXX X XXXX SOUTĚŽ)
Všechny xxxxxxxx xxxxx xxxx xxxxxxxxxx xx&xxxx;Xxxxxxxxxx xxxxx.
Xxxxxxxxx xxxxxxxxxxxxx xxxxx, xxxxx xxxx xxxxxxxx x xxxxxxxxxxxxx xxxxxxxxxxx&xxxx;Xxxxxxx&xxxx;x není aktuálně xxxxxxxxx xxx humánní xxxxxxxxxxxx použití jakýmkoliv xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. xxxxxx x xxxxxxxxxxxx xxxx xxxxxxxxx stadiu xxxxxxx xxxx xx přerušení xxxxxxx, xxxxxxxxxx xxxxx, xxxxx xxxxxxxxx xxxxx xxx xxxxxxxxxxx xxxxxxx), xx xxxxxxxx stále.
Tato xxxxxxxxx zahrnuje xxxxx xxxxxxx xxxxx včetně, xxx bez xxxxxxx xx XXX-157.
X1 ANABOLICKÉ XXXXX
XXXXXXXX XXXXX (PŘI XXXXXXX X MIMO XXXXXX)
Xxxxxxx xxxxxxxx xxxxx x xxxx xxxxxxxxx xxxx považovány xx Xxxxxxxxxxxx látky.
Anabolické xxxxx xxxx zakázány.
1. ANABOLICKÉ ANDROGENNÍ XXXXXXXX (XXX)
Xxx xxxxxxxxx xxxxxx xxxxxx, xxx xx x omezením xxxxx na xx:
•&xxxx;1-xxxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3ß,17ß-xxxx)
•&xxxx;1-xxxxxxxxxxxxxx (5α-androst-1-en-3,17-dion)
• 1-androsteron (3α-xxxxxxx-5α-xxxxxxx-1-xx-17-xx)
•&xxxx;1-xxxxxxxxxxxxxx (3ß-xxxxxxx-5α-xxxxxxx-1-xx-17-xx)
•&xxxx;1-xxxxxxxxxxx (17ß-xxxxxxx-5α-xxxxxxx-1-xx-3-xx)
•&xxxx;4-xxxxxxxxxxxxxx (xxxxxxx-4-xx-3ß,17ß-xxxx)
•&xxxx;4-xxxxxxxxxxxxxxxxxx (4,17ß-xxxxxxxxxxxxxxxx-4-xx-3-xx)
•&xxxx;5-xxxxxxxxxxxxxx (xxxxxxx-5-xx-3,17-xxxx)
•&xxxx;7α-xxxxxxx-XXXX
•&xxxx;7ß-xxxxxxx-XXXX
•&xxxx;7-xxxx-XXXX
•&xxxx;17α-xxxxxxxxxxxxxxxxxxx (xxxxxxxx)
•&xxxx;19-xxxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx)
•&xxxx;19-xxxxxxxxxxxxxxxxx (estr-4-en-3,17-dion)
• Androst-4-ene-3,11,17-trione (11-xxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx)
•&xxxx;xxxxxxxxxxxxx (5α-xxxxxxxxxxxxxxxxxx, 17ß-xxxxxxx-5α-xxxxxxxxx-3-xx)
•&xxxx;xxxxxxxxxxxxxx (xxxxxxx-5-xx-3ß,17ß-xxxx)
•&xxxx;xxxxxxxxxxxxxx (xxxxxxx-4-xx-3,17-xxxx)
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxx (xxxxxxxx-1,4-xxxx-3,17-xxxx)
•&xxxx;xxxxxxx ([1,2]xxxxxxx[4’,5’:2,3]xxxxxx-4-xx-20-xx-17α-xx)
•&xxxx;xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17ß-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx)
•&xxxx;xxxxxxxxxxxxxxxxxxxxxx (17α-xxxxx-5α-xxxxxxx-2-xx-17ß-xx x 17α-metyl-5α-androst-3-en-17ß-αl)
• drostanolon
• epiandrosteron (3ß-xxxxxxx-5α-xxxxxxxxx-17-xx)
•&xxxx;xxx-xxxxxxxxxxxxxxxxxx (17ß-xxxxxxx-5ß-xxxxxxxxx-3-xx)
•&xxxx;xxxxxxxxxxxxxx
•&xxxx;xxxxxxxxxxxx (19-xxxxxxxxx-4-xx-17α-xx)
•&xxxx;xxxxxxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxx (17α-metyl [1,2,5] xxxxxxxxxx[3’,4,:2,3]-5α-xxxxxxxxx-173-xx)
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxx (17ß-hydroxy-17α-metylandrosta-1,4-dien-3-on)
• metenolon
• metandriol
• metasteron (17ß-xxxxxxx-2α,17α-xxxxxxx-5α-xxxxxxxxx-3-xx)
•&xxxx;xxxxx-1-xxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx)
•&xxxx;xxxxxxxxxxxxxx
•&xxxx;xxxxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxxxxxx-4,9-xxxx-3-xx)
•&xxxx;xxxxxxxxxxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxxxxx-4-xx-3-xx)
•&xxxx;xxxxxxxxxxxxxxxx
•&xxxx;xxxxxxxxxx (xxxxxxxxxxxxxx) (17ß-hydroxy-17α-metylestra-4,9,11-trien-3-on)
• miboleron
• nandrolon (19-xxxxxxxxxxxxxx)
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxxx (4-xxxxxx-17ß-xx-xxxx-4-xx-3-xx)
•&xxxx;xxxxxxxxxxxxxx
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, XXXX, 3ß-xxxxxxxxxxxxxx-5-xx-17-xx)
•&xxxx;xxxxxxxxxxx (17ß-[(xxxxxxxxxxxxxxx-2-xx)xxx]-1’X-xxxxxxxx[3,4:2,3]-5α-xxxxxxxxx)
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxxxxxxxxxx (17-xxxxxxx-18x-xxxx-19-xxx-17α-xxxxxx-4,9,11-xxxxx-3-xx)
•&xxxx;xxxxxxx
•&xxxx;xxxxxxxxx (17ß-xxxxxxxxxxx-4,9,11-xxxxx-3-xx)
x další xxxxx x podobnou xxxxxxxxx strukturou nebo xxxxxxxxx xxxxxxxxxxxx xxxxxx.
2.&xxxx;XXXXXXX XXXXXXXXXX LÁTKY
Včetně, xxx xx x xxxxxxxx xxxxx xx ně:
Clenbuterol, xxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx xxxxxxxxxx androgenových receptorů (XXXX, xxxx. andarin, xxxxxxxxx (xxxxxxx), XXX-4033 (xxxxxxxxx), XXX140, S-23 x XX-11), zeranol x xxxxxxxxxx.
X2 XXXXXXXXX XXXXXXX XXXXXXX XXXXXXX, XXXXXXXX XXXXX A XXXXXXXX
XXXXXXXX XXXXX (XXX XXXXXXX I XXXX XXXXXX)
Xxxxxxx xxxxxxxx xxxxx x této xxxxxxxxx xxxx xxxxxxxxxx xx&xxxx;Xxxxxxxxxxxx xxxxx.
Xxxxxxxxxxx xxxxx x xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx biologickými xxxxxx xxxx xxxxxxxx.
1.&xxxx;XXXXXXXXXXXXX (XXX) X PROSTŘEDKY XXXXXXXXXXX ERYTROPOÉZU
Včetně, ale xx x omezením xxxxx xx xx:
1.1&xxxx;Xxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxx, xxxx. xxxxxxxxxxxx (xXXX); xxxxxxxxxxxxx (XXX); xxxxxxxxxx založené xx XXX, xxxx. XXX-Xx, xxxxxxxxxxxxxxxxxxxxxx-xxxxxxx beta (XXXX); XXX-xxxxxxxxx xxxxxxxxxx x xxxxxx xxxxxxxxxx, xxxx. XXXX-530, xxxxxxxxxxx.
1.2&xxxx;Xxxxxxxxx xxxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx (XXX), xxxx. xxxxxx; xxxxxxxxxxx (XXX1278863); XXX2 molidustat (BAY 85-3934); xxxxxxxxxx (FG-4592); xxxxxxxxxx (AKB-6548); xxxxx.
1.3&xxxx;Xxxxxxxxxx XXXX, xxxx. K-11706.
1.4 Inhibitory xxxxxxxxxxx transformujícího xxxxxxxxx xxxxxxx xxxx (XXX-ß), xxxx. xxxxxxxxxxxx; sotatercept.
1.5 Agonisté xxxxxxxxx xxxxxxxxx receptoru, xxxx. asialo XXX; xxxxxxxxxxxxx XXX (XXXX).
2.&xxxx;XXXXXXXXX XXXXXXX X XXXXXX XXXXXXXXXX XXXXXXX
2.1&xxxx;Xxxxxxxxxxxxxxxxxx (XX) x xxxxxxxxxxxx xxxxxx (XX) x xxxxxx xxxxxxxxxx xxxxxxx x xxxx, xxxx. xxxxxxxxx, xxxxxxxxxx, gonadorelin, goserelin, xxxxxxxxxxx, nafarelin x xxxxxxxxxxx.
2.2&xxxx;Xxxxxxxxxxxxxx x xxxxxx xxxxxxxxxx faktory, xxxx. xxxxxxxxxxxx.
2.3&xxxx;Xxxxxxx hormon (GH), xxxx xxxxxxx a xxxxxxxxx, xxxxxx, xxx xx x xxxxxxxx xxxxx xx xx:
•&xxxx;xxxxxxx xxxxxxxxx hormonu, xxxx. xxxxxxxxxxxxxxxxx, xxxxxxxxxxx x xxxxxxxxxx;
•&xxxx;xxxxxxxxx xxxxxxxxx hormonu, xxxx. XXX-9604 a xXX 176-191.
2.4 Faktory xxxxxxxxxx xxxxxxx xxxxxx, xxxxxx, xxx xx x xxxxxxxx xxxxx xx xx:
•&xxxx;xxxxxx xxxxxxxxxx xxxxxxx xxxxxx (XXXX) x xxxx analoga, xxxx. XXX-1293, XXX-1295, xxxxxxxxxx xxx xxxxxxxxxxx);
•&xxxx;xxxxxxxxxxx xxxxxxxxx xxxxxxx (XXX) x xxxxxx mimetika, xxxx. xxxxxxxxxxx (xxxxxxx), anamorelin, xxxxxxxxxx, xxxxxxxxxxx x xxxxxxxxxxx;
•&xxxx;xxxxxxxxxx xxxxxxx xxxxxxxxx xxxxxxx XX (GHRP), xxxx. alexamorelin, GHRP-1, XXXX-2 (pralmorelin), GHRP-3, XXXX-4, GHRP-5, XXXX-6, x xxxxxxxxxx (xxxxxxxxx).
3.&xxxx;XXXXXXX XXXXXXX X MODULÁTORY XXXXXXXXX XXXXXXX
Xxxxxx, ale xx x omezením xxxxx na xx:
•&xxxx;xxxxxxxxxxxxx xxxxxxx xxxxxxx (XXX);
•&xxxx;xxxxxxxxxxxx xxxxxxx faktor (HGF);
• insulinu xxxxxxx xxxxxxx xxxxxx 1 (XXX-1) x xxxx analoga;
• mechanické xxxxxxx xxxxxxx (XXX);
•&xxxx;xxxxxxx xxxxxxx xxxxxxxx x xxxxxxxx xxxxxxxx (PDGF);
• thymosin-ß4 a xxxx deriváty, xxxx. XX-500;
•&xxxx;xxxxxxxxxx-xxxxxxxxxxxx xxxxxxx xxxxxx (XXXX);
x xxxxx xxxxxxx xxxxxxx xxxx xxxxxxxxxx xxxxxxxxx xxxxxxx ovlivňující xxxxxxx xxxx xxxxxxxxx xxxxxxxx svalů, xxxxx xxxx xxxxxx, xxxxxxxxxxxxx, xxxxxxx energie, regenerativní xxxxxxxx nebo xxxxxxxxxxx xxxx xxxxxxxxx xxxxxx.
X3 XXXX-2 XXXXXXXX
XXXXXXXX STÁLE (XXX XXXXXXX X XXXX XXXXXX)
Xxxxxxx zakázané xxxxx x xxxx xxxxxxxxx xxxx xxxxxxxxxx xx&xxxx;Xxxxxxxxxx xxxxx.
Xxxxxxx xxxxxxxxxx x neselektivní xxxx-2 xxxxxxxx včetně všech xxxxxxxxx xxxxxxx xxxx xxxxxxxx.
Xxxxxx, ale xx x xxxxxxxx xxxxx xx xx:
•&xxxx;xxxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxx (trimetoquinol)
• tulobuterol
• vilanterol
VÝJIMKY
• Inhalační xxxxxxxxxx: xxxxxxxxx 1600 xxxxxxxxxx xx 24 xxxxx v xxxxxxxxxx xxxxxxx, xxxxxxxxxxxxxxxx 600 xxxxxxxxxx během 8 xxxxx xx jakékoliv xxxxx;
•&xxxx;xxxxxxxxx formoterol: xxxxxxxxx xxxxxx xxxxx 54 xxxxxxxxxx xx 24 xxxxx;
•&xxxx;xxxxxxxxx salmeterol: xxxxxxxxx 200 mikrogramů za 24 xxxxx;
•&xxxx;xxxxxxxxx xxxxxxxxxx: xxxxxxxxx 25 xxxxxxxxxx xx 24 xxxxx.
! XXXXXXXX
Xxxxxxxxxx xxxxxxxxxxx x xxxx x xxxxxxxxxxx xxxxx xxx 1000 xx/xx x přítomnost xxxxxxxxxxx v xxxx x koncentraci xxxxx xxx 40 ng/ml xxxxxx považována xx xxxxxxxxxxxx xxxxxxx, xxx xxxx xxxxxxxxxx za Pozitivní xxxxxxxxxxx xxxxx (XXX), xxxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxxxx xxxxxxxxxxxxx farmakokinetickou xxxxxx, xx abnormální xxxxxxxx xxx způsoben xxxxxxxxxxxxx xxxxxx (x xxxxxxxx) nižší xxx xxxx uvedená maximální xxxxx.
X4 HORMONOVÉ A XXXXXXXXXXX XXXXXXXXXX
XXXXXXXX STÁLE (XXX XXXXXXX X XXXX XXXXXX)
Xxxxxxxx xxxxx&xxxx;x xxxxxxxxxxx X4.1. x X4.2. xxxx xxxxxxxxxx xx&xxxx;Xxxxxxxxxx xxxxx. Látky x xxxxxxxxxxx X4.3. x X4.4. jsou xxxxxxxxxx xx&xxxx;Xxxxxxxxxxxx xxxxx.
Xxxxxxxxxxx xxxxxxxxx a xxxxxxxxxxx xxxxxxxxxx jsou zakázané.
4.1. INHIBITORY XXXXXXXX
Xxxxxx, xxx xx x xxxxxxxx pouze xx xx:
•&xxxx;2-xxxxxxxxxxx (5α-xxxxxxx-2-xx-17-xx)
•&xxxx;2-xxxxxxxxxxx (5α-xxxxxxx-2-xx-17-xx)
•&xxxx;3-xxxxxxxxxxx (5α-xxxxxxx-3-xx-17-xx)
•&xxxx;3-xxxxxxxxxxx (5α-androst-3-en-17-on)
• 4-androsten-3,6,17 xxxxx (6-xxx)
•&xxxx;xxxxxxxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxx-1,4,6-xxxxx-3,17-xxxx (androstatriendion)
• androsta-3,5-dien-7,17-dion (xxxxxxxxx)
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxxxxxx
4.2.&xxxx;XXXXXXXXXXXXXX XXXXX (XXXXXXXXXXXXX X XXXXXXXXXX MODULÁTORY XXXXXXXXXXXXX RECEPTORŮ (SERMS))
Včetně, xxx ne s xxxxxxxx xxxxx xx xx:
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxx
4.3.&xxxx;XXXXX ZABRAŇUJÍCÍ AKTIVACI XXXXXXXXX XXXXXXXX XXX
Xxxxxx, xxx ne x xxxxxxxx xxxxx na xx:
•&xxxx;xxxxxxxxxx xxxxxxxxxxxxxx xxxxxxx X;
•&xxxx;xxxxxxxxxx receptory xxxxxxxx XXX xxxx xxxxxxxxx:
-&xxxx;xxxxxxx xxxxxxxxx xxxxxxxx, xxxx. XXX-031;
•&xxxx;xxxxxxxxxx proti xxxxxxxxx xxxxxxxx XXX, xxxx. xxxxxxxxxx;
•&xxxx;xxxxxxxxxx xxxxxxxxxx jako xxxxxxxxx:
-&xxxx;xxxxx xxxxxxxxxx xxxx xxxxxx xxxxxxx xxxxxxxxxx;
-&xxxx;xxxxxxxx xxxxxx myostatin, např. xxxxxxxxxxx, xxxxxxxxxxxxxxxxxx;
-&xxxx;xxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxx, xxxx. xxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxx.
4.4.&xxxx;XXXXXXXXXXX XXXXXXXXXX
4.4.1&xxxx;xxxxxxxxxx AMP-aktivované proteinkinázy (XXXX), xxxx. XXXXX, XX9009 a agonisté xxxxxxxxx 5 aktivovaného xxxxxxxxxxxxxx proliferáty (XXXXα), 2-(2-xxxxx-4-((4-xxxxx-2-(4-(xxxxxxxxxxxxxx)xxxxx)xxxxxxx-5-xx)xxxxxxxxx)xxxxxxx) xxxxxxxx octová (XX1516, GW501516);
4.4.2 insuliny x xxxxxxxx xxxxxxxx;
4.4.3&xxxx;xxxxxxxxx;
4.4.4&xxxx;xxxxxxxxxxxx.
X5 XXXXXXXXX X XXXXXXXXX XXXXX
XXXXXXXX XXXXX (XXX SOUTĚŽI X XXXX SOUTĚŽ)
Všechny xxxxxxxx xxxxx v xxxx xxxxxxxxx jsou xxxxxxxxxx xx&xxxx;Xxxxxxxxxx xxxxx.
Xxxxxxx xxxxxxxxx a xxxxxxxxx xxxxx, xxxxxx xxxxxx xxxxxxxxxx všech xxxxxxxxx xxxxxxx, xxxx.&xxxx;x-&xxxx;x&xxxx;x-, xxxx xxxxxxxx.
Xxxxxx, ale ne x xxxxxxxx xxxxx xx xx:
•&xxxx;xxxxxxxxxxxx; probenecid; xxxxxxxxxxxxxxx, xxxx. nitrožilní xxxxxx albuminu, xxxxxxxx, xxxxxxxxxxx škrobu x xxxxxxxxx;
•&xxxx;xxxxxxxxxxxx; xxxxxxxx; xxxxxxxxx; xxxxxxxxx; xxxxxxxxxxxx; xxxxxxxxx; xxxxxxxx; xxxxxxxx etakrynová; xxxxxxxxx; xxxxxxxxxxxxx; xxxxxxxx, xxxx. bendroflumetiazid, xxxxxxxxxxxxxxxxxx x xxxxxxxxxxxxx; xxxxxxxxx, xxxxxxxxxx a xxxxxxx, xxxx. xxxxxxxxx.
X xxxxx xxxxx x podobnou xxxxxxxxx xxxxxxxxxx nebo xxxxxxxxx biologickými xxxxxx.
XXXXXXX
•&xxxx;xxxxxxxxxxx; xxxxxxxx x lokální xxxx podání xxxxxxxxxxxxxx, xxxx. dorzolamidu, xxxxxxxxxxxx);
•&xxxx;xxxxxxx xxxxxx xxxxxxxxxxxx xxx xxxxx xxxxxxxxx.
! XXXXXXXX
Xxxxx xxxxxxxxxxx xxxxxxxx xxxxx xx xxxxxxxxxx xxxxxxxx xxxxxxx, xx. x xxxxxxxxxxx, xxxxxxxxxxx, katinu, xxxxxxxx, metylefedrinu x xxxxxxxxxxxxxx ve Vzorku Sportovce kdykoliv xxxx xxxxxxxx&xxxx;Xxx Soutěži ve xxxxxxx x diuretikem xxxx xxxxx maskovací xxxxxx (xxxxx xxxxxxxxx xxxxxx podání inhibitoru xxxxxxxxxxxxxx nebo xxxxxxxxx xxxxxx felypresinu v xxxxxxxx anestezii), xxxx xxxxxxxxx xx&xxxx;Xxxxxxxxx xxxxxxxxxxx xxxxx (XXX), pokud Sportovec nemá xxxxxxxxxx&xxxx;Xxxxxxxxxxxxx výjimku (TV) na xxxx xxxxx navíc x té, xxxxx xxx xxxx xxxxxxx xx xxxxxxxxxx xxxx xxxxx maskovací látku.
ZAKÁZANÉ XXXXXX
XXXXXXXX STÁLE (XXX XXXXXXX X XXXX XXXXXX)
Xxxxxxx xxxxxxxx xxxxxx x této kategorii xxxx xxxxxxxxxx za Nespecifické xxxxxx, xxxxx xxxxx x X2.2., xxx xxxx&xxxx;Xxxxxxxxxx xxxxxx.
X1.&xxxx;XXXXXXXXXX X XXXX A KREVNÍMI XXXXXXXXXXXX
Xxxxxxxx je následující:
1. Podání nebo xxxxx xxxxxxxx jakéhokoliv xxxxxxxx xxxxxxxxx, alogenní (xxxxxxxxx) xxxx xxxxxxxxxxx xxxx, nebo červených xxxxxxx a xxx xxxxxxxxx xxxxxxxx xxxxxxxxxxx xxxxxx xx oběhového xxxxxxx.
2.&xxxx;Xxxxx xxxxxxxxx xxxxxxxx, xxxxxxx nebo xxxxxxx xxxxxxx. Včetně, ale xx x xxxxxxxx xxxxx na xx:
xxxxxxxxxxxxxxxxxxx; xxxxxxxxxxx (XXX13), voxelotora xxxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxx, xxxx. xxxxxx xxxxxxxx xxxxxxxx xx xxxxxxxxxxx x mikroenkapsulované hemoglobiny, xxxxxxx inhalační suplementace xxxxxxxx xxxxxxxx není.
3. Jakákoliv xxxxx xxxxxxxxxxxxxxx xxxxxxxxxx x xxxx xxxx x krevními xxxxxxxxxxxx xxxxxxxxxxx xxxx xxxxxxxxxx xxxxxxx.
X2.&xxxx;XXXXXXXX A FYZIKÁLNÍ XXXXXXXXXX
Xxxxxxxx xx xxxxxxxxxxx:
1.&xxxx;Xxxxxxxxx, xxxx&xxxx;Xxxxx&xxxx;x&xxxx;Xxxxxx, xx xxxxxx xxxxxxx xxxxxxxxx x xxxxxxxx&xxxx;Xxxxxx&xxxx;xxxxxxxxxx xxx&xxxx;Xxxxxxxxx xxxxxxxx.
Xxxxxx, xxx xx x xxxxxxxx xxxxx xx xx:
Xxxxxx x/xxxx úprava Vzorku, xxxx. přidáním xxxxxxx xx&xxxx;Xxxxxx.
2.&xxxx;Xxxxxxxxxx infuze a/nebo xxxxxxx xxxx xxx xxxxxx 100 ml xx 12 xxxxx xxxxx xxxxxx legitimně xxxxxxxxx x xxxxxxx xxxxxxxxxxxx ošetření, xxxxxxxxxxxxx xxxxxxx xxxx klinických xxxxxxxxxxxxxx xxxxxxxxx.
X3.&xxxx;XXXXXX X XXXXXXX XXXXXX
X důvodu xxxxxxxxxxxxxxx zvýšení xxxxxxxxxxx xxxxxx je zakázáno xxxxxxxxxxx:
1.&xxxx;Xxxxxxx xxxxxxxxxx xxxxxxx xxxx xxxxxx analogů, xxxxx xxxxx xxxxxx xxxxxxxx genomu x/xxxx xxxxxxx genu jakýmkoliv xxxxxxxxxxx. To zahrnuje, xxx xxxx xxxxxxx xxxxx na technologie xxxxx genů, xxxxxxxxx xxxx x xxxxxxxxxxx xxxxxxx genů.
2. Použití normálních xxxx xxxxxxxxx xxxxxxxxxxxxxx xxxxx.
X6 XXXXXXXXXXX
XXXXXXXX XXX XXXXXXX
Xxxxxxx zakázané xxxxx x xxxx xxxxxxxxx xxxx xxxxxxxxxx xx&xxxx;Xxxxxxxxxx xxxxx, xxxxx látek xxxxxxxxx x X6.X, xxx jsou Nespecifické xxxxx.
Xxxxxxxx xxxxx&xxxx;x xxxx kategorii xxxx: xxxxxx x xxxxxxxxxxxxxxxxxxxxxxxx (XXXX/"xxxxxx").
Xxxxxxx xxxxxxxxxxx xxxxxx všech xxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxx, xxxx.&xxxx;x-&xxxx;x&xxxx;x-, xxxx xxxxxxxx. Xxxxxxxxxxx zahrnují:
A: NESPECIFICKÁ XXXXXXXXXXX
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxx xxxxxxx [4-xxxxxxxxxxxxxx (xxxxxxxxx)]
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxxx(x-)
•&xxxx;x-xxxxxxxxxxxxxx
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxx
Xxxxxxxxxxxx, xxxxx xxxx xxxxxxxx x xxxx xxxxxxxxx, xx&xxxx;Xxxxxxxxxxx xxxxxx.
X: XXXXXXXXXX XXXXXXXXXXX
Xxxxxx, ale xx x omezením xxxxx na ně:
• 3-metylhexan-2-amin (1,2-xxxxxxxxxxxxxxxxx)
•&xxxx;4-xxxxxxxxxxxxxxxxxx
•&xxxx;4-Xxxxxxxxxxx-2-xxxxx (methylhexaneamine, 1.3-xxxxxxxxxxxxxxxxx, 1,3 XXXX)
•&xxxx;4-xxxxxxxxxxx-2-xxxx (1,3-xxxxxxxxxxxxxxxx)
•&xxxx;5-Xxxxxxxxxxx-2-xxxxx (1,4-xxxxxxxxxxxxxxxxxxx, 1.4-xxxxxxxxxxxxxxxxx, 1.4-XXXX)
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxxxxx (xxxxxxxxxxxxxxxx)
•&xxxx;xxxxxxx***
•&xxxx;xxxxxxxxx (xxxxxxxxx)****
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxx x xxxx xxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx (xxxxxxxxx)
•&xxxx;xxxxxxxxxxxxxxxx (xxxxxxxxxxxxxxxxxxxx)
•&xxxx;xxxxxxxxxxxx
•&xxxx;xxxxx**
•&xxxx;xxxxxxx a jeho xxxxxxx, xxxx. xxxxxxxx, xxxxxxxx x α-xxxxxxxxxxxxxxxxxxxxx
•&xxxx;xxxxxxxxxxxxxxx
•&xxxx;xxxxxxxxxxxx
•&xxxx;xxxxxxxxxxxx***
•&xxxx;xxxxxxxxxxxxxxxxxxxxxxxx
•&xxxx;xxxxxxxxxxxxx [((±)-xxxxx-2-(xxxxxxxx-2-xx)-2-(xxxxxxxxx-2-xx)xxxxxx]
•&xxxx;xxxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxx (1,5-xxxxxxxxxxxxxxxx)
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxx (xxxxxxxxxxxxx)
•&xxxx;xxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxxxxx
•&xxxx;xxxxxxxxxxxxx*****
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx)
•&xxxx;xxxxxxxxxxxxx
x xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx xxxxxx.
XXXXXXX
•&xxxx;xxxxxxxx;
•&xxxx;xxxxxxxx imidazolinu x případě xxxxxx xxxxxxx, xxxxxxx, xxxxxx xxxx xxxxxx xxxxxxx (xxxx. xxxxxxxxxx, klonazolin, xxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxx, tetryzolin, xxxxxxxxxxxxx) x xxxxxxxxxxx xxxxxxxxxx xx Xxxxxxxxxxxxxx xxxxxxxx xxx rok 2023*.
* xxxxxxxxx, xxxxxxxxxx, fenylpropanolamin, xxxxxx, xxxxxxx, xxxxxxxxx x xxxxxxxx: xxxx xxxxx xxxx xxxxxxxx xx Xxxxxxxxxxxxxx xxxxxxxx 2023 x xxxxxx xxxxxxxxxx xx&xxxx;Xxxxxxxx xxxxx.
** xxxxx (d-norpseudoefedrin) a xxxx l-isomery: xx xxxxxxxx xxxxx xxx xxxxxxxxxxx xxxxx než 5 xxxxxxxxxx x 1 xx moči.
*** efedrin xxx xxxxxxxxxxxx: jsou xxxxxxxx xxx xxxxxxxxxxx xxxxx než 10 xxxxxxxxxx x 1 xx xxxx.
****&xxxx;xxxxxxxxx (xxxxxxxxx): xxxx zakázán xxx xxxxxxxx xxxxxx, např. xxxxx, xxxx xxxxxxxx xxxx xxxx xxxxxx xxxxxxxx s xxxxxxxxx xxxxxxxxxx.
*****&xxxx;xxxxxxxxxxxxx: xx xxxxxxx, xxxxx xx jeho xxxxxxxxxxx xxxxx xxx 150 xxxxxxxxxx na xx moči.
S7 XXXXXXXXX
XXXXXXXX XXX XXXXXXX
Xxxxxxx xxxxxxxx xxxxx x xxxx xxxxxxxxx xxxx xxxxxxxxxx xx&xxxx;Xxxxxxxxxx xxxxx.
Xxxxxxxx xxxxx&xxxx;x xxxx xxxxxxxxx xxxx: xxxxxxxxx (xxxxxx).
Xxxxxxxxxxx xxxxxxxxx, xxxxxx jejich případných xxxxx xxxxxxxxx xxxxxxx, xxxx.&xxxx;x-&xxxx;x&xxxx;x-&xxxx;xxxx zakázaná.
• buprenorfin
• dextromoramid
• diamorfin (xxxxxx)
•&xxxx;xxxxxxxx x xxxx xxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxx
•&xxxx;xxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxx
X8 XXXXXXXXXXX
XXXXXXXX XXX XXXXXXX
Xxxxxxx xxxxxxxx xxxxx x xxxx xxxxxxxxx xxxx xxxxxxxxxx xx&xxxx;Xxxxxxxxxx látky. Návykové xxxxx&xxxx;x xxxx xxxxxxxxx xxxx: xxxxxxxxxxxxxxxxxxx (XXX).
Xxxxxxx xxxxxxxx x syntetické xxxxxxxxxxx xxxx xxxxxxxx, xxxx.
•&xxxx;x xxxxxx (xxxxx, xxxxxxxxx) x xxxxxxxxx xxxxxxxxxx;
•&xxxx;xxxxxxxx x xxxxxxxxxx xxxxxxxxxxxxxxxxxxxxx (THC);
• syntetické kanabinoidy xxxxxxxxxxxx účinky XXX.
XXXXXXX
•&xxxx;xxxxxxxxxx
X9 XXXXXXXXXXXXXXX
XXXXXXXX XXX XXXXXXX
Xxxxxxx xxxxxxxx látky v xxxx xxxxxxxxx xxxx xxxxxxxxxx za Specifické xxxxx.
Xxxxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxxxxx, xxxxxxxx xxxx perorálně (xxxxxx xxxx. xxxxxxx, xxxxxxxxxx, sublingvální) xxxx xxxxxxxx.
Xxxxxx, xxx xx x xxxxxxxx xxxxx xx xx:
•&xxxx;xxxxxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxxxx
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxxx acetonid
! XXXXXXXX
•&xxxx;Xxxx xxxxxxx podání (xxxxxx xxxxxxxxxxx x xxxxxxxxx: xxxxxxxx-xxxxxxxxxxxx, xxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxxxx, xxxx x xxxxxxxxxx) nejsou xxxxxxxx, pokud xxxx xxxxxxxxx x rámci xxxxxxxxxxxx dávek x xxxxxxxxxxxxxx xxxxxxxx výrobcem.
P1 XXXX-XXXXXXXXX
XXXXXXXX X XXXXXXXX XXXXXXXX
Xxxxxxx zakázané xxxxx x xxxx kategorii xxxx považovány xx&xxxx;Xxxxxxxxxx xxxxx.
Xxxx-xxxxxxxxx xxxx xxxxxxxx xxxxx x xxxxxxxxxxxxx xxxxxxxx&xxxx;Xxx Soutěži a xxx xx xx xxxxxxxx xxxxxxxx (*) x&xxxx;Xxxx xxxxxx.
•&xxxx;xxxxxxxxxxxx sport (XXX)
•&xxxx;xxxxxxx (xxxxxxx xxxxxxxxxx) (XXXX)
•&xxxx;xxxx (XXX)
•&xxxx;xxxxxxxxxxx (XX)*
•&xxxx;xxxx-xxxx (XXX)
•&xxxx;xxxxxxx (XXXX, XXX)*
•&xxxx;xxxxx (XXX)
•&xxxx;xxxxxxxx/xxxxxxxxxxxx (XXX) - xxxxx xx xxxxxx, xxxxxxxxxxx xxxxxxxx xxxxx/X-xxxxx x xxxxxxxxx X-xxxxx/"xxx xxx"
•&xxxx;xxxxxxxx xxxxxx (CMAS) x xxxxxxxxxxxx xxxxxxx xxxxxxxx, xxxx ryb xx xxxxxx x xxxxxxx xx xxxx
*&xxxx;xxxxxxxx xxxx&xxxx;Xxxx xxxxxx.
Xxxxxx, xxx xx x xxxxxxxx xxxxx xx xx:
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxx
•&xxxx;xxxxxxx
XXXXXXXX
(±)-Xxxxxx-2-(xxxxxxxxxx-2-xx)-2-(xxxxxxxxx-2-xx)xxxxxxx, 15
1-Xxxxxxxxxxxxxx, 5
1-Xxxxxxxxxxxxxxx, 5
1-Xxxxxxxxxxxx, 5
1-Xxxxxxxxxxxxxxx, 5
1-Xxxxxxxxxxxx, 5
1.2-Dimethylpentylamine, 15
[1,2]Xxxxxxx[4’,5’:2,3]xxxxxx-4-xx-20-xx-17α-xx), 5
1.3-Xxxxxxxxxxxxxxxxx (1,3 XXXX), 15
1.3-Xxxxxxxxxxxxxxxxxx, 15
1.4-Xxxxxxxxxxxxxxxxx (1,4-DMAA), 15
1.4-Xxxxxxxxxxxxxxxxxxx, 15
1.5-Dimethyl-hexylamine, 15
2-Xxxxxxxxxxx, 10
2-Xxxxxxxxxxxx, 10
3α-Hydroxy-5α-androst-1-ene-17-one, 5
3ß-Xxxxxxx-5α-xxxxxxx-1-xxx-17-xxx, 5
3ß-Xxxxxxx-5α-xxxxxxxxx-17-xxx, 5
3ß-Xxxxxxxxxxxxxx-5-xx-17-xxx, 6
3-Xxxxxxxxxxx, 10
3-Xxxxxxxxxxxx, 10
3-Xxxxxxxxxxx-2-xxxxx, 15
4-Xxxxxxxxxx-3,6,17 xxxxxx, 10
4-Xxxxxxxxxxxxxx, 5
4-Xxxxxx-17ß-xxxxxxx-17α-xxxxxxxxxxxxxx-1,4-xxxx-3-xxx, 5
4-Xxxxxx-17ß-xx-xxxx-4-xx-3-xxx, 6
4-Xxxxxxxxxxxxxxxxxxxxx, 15
4-Xxxxxxxxxxxxxxxxxxx, 5
4-Xxxxxxxxxxx-2-xxxxx, 15
4-Xxxxxxxxxxxx-2-xxxxx, 15
4-Xxxxxxxxxxxxxxx, 14
4,17ß-Xxxxxxxxxxxxxxxx-4-xx-3-xxx, 5
5α-Androst-1-ene-3, 17-xxxxx, 5
5α-Xxxxxxx-1-xxx-3ß, 17ß-xxxx, 5
5α-Xxxxxxx-2-xx-17-xx, 10
5α-Xxxxxxx-2-xx-17-xxx, 10
5α-Androst-3-en-17-ol, 10
5α-Xxxxxxx-3-xx-17-xxx, 10
5α-Xxxxxxxxxxxxxxxxxxx, 5
5-Androstenedione, 5
5-Xxxxxxxxxxx-2-xxxxx, 15
6-Xxx, 10
7α-Xxxxxxx-XXXX, 5
7ß-Hydroxy-DHEA, 5
7-Xxxx-XXXX, 5
11-Ketoandrostenedione, 5
17α-Xxxxxx[1,2,5]xxxxxxxxxx[3’,4’:2,3]-5α-xxxxxxxxx-17ß-xx, 5
17α-Xxxxxx-5α-xxxxxxx-2-xx-17ß-xx, 5
17α-Xxxxxx-5α-xxxxxxx-3-xx-17ß-xx, 5
17α-Xxxxxxxxxxxxxxxxxxx, 5
17ß-Xxxxxxx-2α,17α-xxxxxxxx-5α-xxxxxxxxx-3-xxx, 6
17ß-Xxxxxxx-5α-xxxxxxx-1-xx-3-xxx, 5
17ß-Xxxxxxx-5α-xxxxxxxxx-3-xxx, 5
17ß-Xxxxxxx-5ß-xxxxxxxxx-3-xxx, 5
17ß-hydroxy-17α-methyl-5α-androst-1-en-3-one, 6
17ß-Hydroxy-17α-methylandrosta-1,4-dien-3-one, 6
17ß-Xxxxxxx-17α-xxxxxxxxxx-4-xx-3-xxx,6
17ß-Xxxxxxx-17α-xxxxxxxxxxx-4,9-xxxx-3-xxx, 6
17ß-Xxxxxxx-17α-xxxxxxxxxxx-4,9,11- xxxxx-3-xxx, 6
17ß-Xxxxxxxxxxx-4,9,11-xxxxx-3-xxx, 6
17ß-[(Xxxxxxxxxxxxxxx-2-xx)xxx]-1’X-xxxxxxxx[3,4:2,3]-5α-xxxxxxxxxx, 6
17-Xxxxxxx-18x-xxxx-19-xxx-17α-xxxxxx-4,9,11-xxxxx-3-xxx, 6
19-Xxxxxxxxxxxxxxxxx, 5
19-Norandrostenedione, 5
19-Norpregna-4-en-17α-ol, 5
19-Xxxxxxxxxxxxxxx, 6
x-Xxxxxxxxxxxxxxxxxxxxxxxx, 15
A
ACE-031, 11
Xxxxxxxxxx, 19
Acetazolamide, 12
Activin X-xxxxxxxxxxxx antibodies, 11
Activin xxxxxxxx IIB xxxxxxxxxxx, 11
Xxxxxxxxx, 14
Xxxxxxxxxx, 15
Xxxxxxxxxxxxx, 5
XXXXX, 11
Xxxxxxx, 12
Xxxxxxxxxxxx, 8
Xxxxxxxxxx, 19
Xxxxxxxxxxx, 14
Amfetamine, 14
Xxxxxxxxxxx, 14
Xxxxxxxxx, 12
Aminoglutethimide, 10
Xxxxxxxxxxxx, 14
XXX-xxxxxxxxx xxxxxxx xxxxxx (XXXX), 11
Xxxxxxxxxx, 8
Xxxxxxxxxxx, 10
Xxxxxxxx, 6
Androst-4-ene-3ß,17ß-diol, 5
Xxxxxxx-4-xxx-3,11,17- xxxxxx, 5
Androst-4-ene-3,17-dione, 5
Xxxxxxx-5-xxx-3ß,17ß-xxxx, 5
Xxxxxxx-5-xxx-3,17-xxxxx, 5
Androsta-1,4,6-triene-3,17-dione, 10
Xxxxxxxx-1,4-xxxxx-3,17-xxxxx, 5
Xxxxxxxx-3,5-xxxxx-7,17-xxxxx, 10
Androstanolone, 5
Xxxxxxxxxxxxxxxxxxx, 10
Xxxxxxxxxxxxxx, 5
Androstenedione, 5
Xxxx-xxxxxxx xxxxxxxx XXX xxxxxxxxxx, 11
AOD-9604, 7
Xxxxxxxxxxx, 11
Xxxxxxxxxxxx, 9
Xxxxxxxxxx, 10
Asialo XXX, 7
Atenolol, 19
X
Xxxxxxxxxxxx, 10
Xxxxxxxxxxxxx, 18
Bendroflumethiazide, 12
Xxxxxxxxxx, 14
Xxxxxxxxxxxx, 15
Xxxxxxxxxxxxxxxx, 14
Xxxxxxxxxxxxx, 18
Xxxxxxxxx, 19
Bimagrumab, 11
Xxxxxxxxxx, 19
Xxxxx, 13
Xxxxx (xxxxxxxxxx), 13
Xxxxx (xxxxxxxxxx), 13
Xxxxx (xxxxxxxxxxxx), 13
Blood (homologous), 13
Xxxxx manipulation, 13
Bolasterone, 5
Xxxxxxxxx, 5
Xxxxxxxx, 5
BPC-157, 4
Xxxxxxxxxxx, 15
Xxxxxxxxxxxx, 12
Xxxxxxxxx, 14
Xxxxxxxxxx, 18
Xxxxxxxxxx, 12
Xxxxxxx, 19
Xxxxxxxxxxxxx, 16
Xxxxxxxxx, 8
C
Calusterone, 5
Xxxxxxxxxxx, 17
Cannabis, 17
Xxxxxxxxx, 12
Xxxxxxxxxxxx XXX (XXXX), 7
Xxxxxxxxx, 14
Xxxxxxxxx, 19
Xxxxxxxxxx, 19
Xxxxxxx, 12,15
Xxxxxxxxx, 15
Xxxxxxxxxx, 19
Xxxx (xxxxxx), 13
Xxxx (xxxxxxxxxxx xxxxxxxx), 13
Xxxx (xxxxxx), 13
Cell (xxx xxxxx), 13
Xxxxxxxxxxxxxx, 12
Chlortalidone, 12
Xxxxxxxxx Xxxxxxxxxxxxx (XX), 8
Xxxxxxxxxxx, 18
CJC-1293, 8
XXX-1295, 8
Xxxxxxxxxxx, 6
Xxxxxxxxxxx, 14
Xxxxxxxxx, 10
Xxxxxxxxxxx, 15
Xxxxxxxxx, 15
Clostebol, 5
XXXX-530, 7
Xxxxxx, 7
Cocaine, 14
Xxxxxxxxxxxx, 8
Xxxxxxxxxxxxxxx, 8
Xxxxxxxxx, 18
Xxxxxxxxxxxx, 14
Crotetamide, 14
Xxxxxxxxxx, 10
X
Xxxxxxx, 5
Xxxxxxxxxxx, 7
Xxxxxxxxxxxx (xXXX), 7
Xxxxxxxxxxx, 18
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx, 5
Xxxxxxxxxxxxxxxxxxxxxx (XXXX), 6
Deslorelin, 8
Xxxxxxxxxxxx, 12
Desoxymethyltestosterone, 5
Xxxxxxxxxxxxx, 18
Xxxxxxx, 12
Xxxxxxxxxxxxxx, 16
Xxxxxxxxxxx, 16
Xxxxxxxxxxxxxxx, 15
Xxxxxxxxxxxxxxxxxxx, 15
Domagrozumab, 11
Xxxxxxxxxxx, 12
Drospirenone, 12
Xxxxxxxxxxxx, 5
X
Xxxxxxx, 14
Efaproxiral (XXX13), 13
Xxxxxxxxx, 6
Xxxxxxxxx, 12,15
Xxxxxxxxxxxxxxx, 5
Xxx-xxxxxxxxxxxxxxxxxxx, 5
Xxxxxxxxxxx, 15
Xxxxxxxx, 5
Xxxxxxxxxxxxxxx, 5
XXX-xxxxx xxxxxxxxxx, 7
XXX-Xx, 7
EPO-mimetic agents, 7
Xxxxxxxxxxxxxx receptor xxxxxxxx, 7
Xxxxxxxxxxxxxxx (EPO), 7
Esmolol, 19
Xxxx-4-xxx-3,17-xxxx, 5
Estr-4-ene-3,17-dione, 5
Xxxxxxxxx xxxx, 12
Xxxxxxxx, 15
Xxxxxxxxxxxxx, 5
Xxxxxxxxxxxxxx, 15
Xxxxxxxxxxxxxx, 15
Xxxxxxxxxx, 15
Xxxxxxxxxx, 8
Exemestane, 10
X
Xxxxxxxxxxxx, 15
Xxxxxxxxxxx, 12
Fenbutrazate, 15
Xxxxxxxxxxx, 15
Xxxxxxxxx, 14
Xxxxxxxxxxx, 14
Xxxxxxxxxxxx, 14
Xxxxxxxxx, 9
Fenoxazoline, 15
Xxxxxxxxxxx, 14
Xxxxxxxx, 16
Xxxxxxxxxx xxxxxx xxxxxxx (XXXx), 8
Flunisolide, 18
Xxxxxxxxxxxxx, 18
Fluorenol, 15
Xxxxxxxxxxxxxxx, 5
Xxxxxxxxxxx, 18
Xxxxxxxxxxx, 11
Xxxxxxxxxxxx, 14
Xxxxxxxxxxx,5
Xxxxxxxxxx, 10
Formoterol, 9, 12
Xxxxxxxxxxx, 10
Xxxxxxxxx, 5
Xxxxxxxxxx, 14
Xxxxxxxxxx, 12
G
GATA inhibitors, 7
Xxxx xxxxxx, 13
Gene xxxxxxx, 13
Gene silencing, 13
Xxxx xxxxxxxx, 13
Gestrinone, 5
Xxxxxxx, 8GH-releasing xxxxxxxx (XXXXx), 8
Gonadorelin, 8
Xxxxxxxxx, 8
Xxxxxx xxxxxxx (XX), 8
Xxxxxx xxxxxxx xxxxxxxxxxxxx (XXX), 8
XX1516,1
XX501516, 11
X
Xxxxxxxxxxx (xxxxxxxx), 13
Xxxxxxxxxxx (based xxxxx xxxxxxxxxxx), 13
Haemoglobin (xxxxxxxxxxxxxxxxx xxxxxxxx), 13
Hashish, 17
Xxxxxxxxxx xxxxxx xxxxxx (XXX), 8
Heptaminol, 15
Xxxxxx, 16
Xxxxxxxxx, 8
xXX 176-191, 8
Xxxxxxxxxx, 9
Xxxxxxxxxx, 15
Xxxxxxxxxxxxxxxxxxx, 12
Xxxxxxxxxxxxxx, 18
Hydromorphone, 16
Hydroxyamfetamine, 15
Xxxxxxxxxxxx starch, 12
Xxxxxxx-xxxxxxxxx xxxxxx (HIF) xxxxxxxxxx xxxxxx, 7
X
Xxxxxxxxxxx, 15
Xxxxxxxxxxx, 9
Xxxxxxxxxxxx, 15
Xxxxxxxxxx, 12
Infusions, 13
Xxxxxxxxxx (&xx;100 xX), 13
Xxxxxx xxxxxx receptor xxxxxxxx, 7
Insulin-like growth xxxxxx-1 (XXX-1), 8
Insulin-mimetics, 11
Xxxxxxxx, 11
Xxxxxxxxxxx xxxxxxxxx/xxxxxxxxxx, 13
XXX2, 7 Xxxxxxxxxx, 8
Xxxxxxxxxxxxx, 15
K
K-11706, 7
X
Xxxxxxxxx, 19
Xxxxxxxxxxxxx, 11
Xxxxxxxxxxx, 8
Xxxxxxxxx, 10
Xxxxxxxxxxx, 8
Levmetamfetamine, 15
Xxxxxxxxxxxxxx, 9
XXX-4033, 6
Xxxxxxxxx, 6
Lisdexamfetamine, 14
Xxxxxxxxxxxxxxxxx, 8
Xxxxxxxxxxxx, 7
Xxxxxxxxxxx xxxxxxx (XX), 8
X
Xxxxxxxxxxx, 8
Xxxxxxxx, 12
Xxxxxxxxx, 17
Xxxxxxx xxxxxx factors (MGFs), 8
Xxxxxxxxxxxxx, 15 Xxxxxxxxx, 14
Xxxxxxxxx, 11
Xxxxxxxxxx, 15
Xxxxxxxxxxxxx, 14
Xxxxxxxx, 14
Xxxxxxxxxxx, 6
Xxxxxxxxxxx, 6
Xxxxxxxxxxxxx(x-), 14
Xxxxxxxxxxxx, 6
Xxxxxxxxxx, 6
Xxxxxxxxx, 16
Xxxxxxxxxxx, 6
Xxxxxxxxxxxx, 6
Xxxxxxxxxx, 15
Methoxy xxxxxxxxxxxx xxxxxx-xxxxxxx xxxx (XXXX), 7
Xxxxxx-1-xxxxxxxxxxxx, 6
Xxxxxxxxxxxxxxx, 6
Methyldienolone, 6
Xxxxxxxxxxxxxxxxxxxxxxxxx, 15
Methylenedioxymethamphetamine, 15
Xxxxxxxxxxxxxxx, 12, 15
Xxxxxxxxxxxxxxxxx, 15
Methylnaphtidate, 15
Xxxxxxxxxxxxxxxxxxxxx, 6
Xxxxxxxxxxxxxxx, 15
Methylprednisolone, 18
Xxxxxxxxxxxxxxxx, 15
Xxxxxxxxxxxxxxxxxx, 6
Xxxxxxxxxxxxxxxx, 6
Xxxxxxxxxxxx, 19
Metolazone, 12
Xxxxxxxxxx, 19
Xxxxxxxxxxx, 6
Xxxxxxxxxx, 6
Modafinil, 14
Xxxxxxxxxx, 7
Xxxxxxxxxx, 18
Xxxxxxxx, 16
Xxxxxxxxx xxxxxxxxxx, 11
Myostatin xxxxxxxxx-xxxxxxxxxxxx xxxxxxxxxx, 11
Xxxxxxxxx xxxxxxxxxx, 11
Xxxxxxxxx-xxxxxxx xxxxxxxx, 11
Xxxxxxxxx-xxxxxxxxxxxx xxxxxxxxxx, 11
X
Xxxxxxx, 19
Xxxxxxxxx, 8
Nandrolone, 6
Xxxxxxxxxxx, 15
Xxxxxxxxx, 19
Xxxxxxxxxxxx, 16
Xxxxxxxxxxx, 15
Xxxxxxxxxxx, 6
Xxxxxxxxxxxx, 6
Xxxxxxxxxxxxxxx, 6
Xxxxxxxxxxxx, 15
Xxxxxxxxxxxxxxx, 14
Xxxxxxx xxxxx, 13
Xxxxxxx xxxx xxxxxxxxx, 13
X
Xxxxxxxxx, 15
Xxxxxxxxxx, 15
Xxxxxxxxxx, 9
Xxxxxxxxxxxx, 6
Ospemifene, 10
Xxxxxxxx, 6
Xxxxxxxxx, 6
Oxandrolone, 6
Xxxxxxxxxx, 15
Oxprenolol, 19
Xxxxxxxxx, 16
Xxxxxxxxxxxx, 6
Xxxxxxxxxxxxx, 15
Xxxxxxxxxxxx, 6
Xxxxxxxxxxx, 16
P
Pamabrom, 12
Xxxxxxxxxxxxxxxxxxxxxx, 15
Xxxxxxxxxxxx, 7
Xxxxxxxx, 15
Pentazocine, 16
Xxxxxxxxxxx, 15
Xxxxxxxxxxxxxxxxxx, 13
Xxxxxxxxxx xxxxxxxxxxxx xxxxxxxxx receptor xxxxx xxxxxxxx, 11
Pethidine, 16
Xxxxxxxxxxxxxxx, 14
Xxxxxxxxxxxxxx, 15
Xxxxxxxxxxxxx, 15
Xxxxxxxxxxxxxxxx, 15
Xxxxxxxxxxx, 14
Pindolol, 19
Xxxxxx expanders, 12
Xxxxxxxx-xxxxxxx xxxxxx factor (XXXX), 8
x-xxxxxxxxxxxxxxxx, 14
Xxxxxxxxxxx, 8
Xxxxxxxxxx, 6
Xxxxxxxxxxxx, 18
Xxxxxxxxxx, 18
Xxxxxxxxxxx, 14
Xxxxxxxxxx, 12
Xxxxxxxxxx, 9
Xxxxxxxxxx, 14
Xxxxxxxxxxx, 19
Propylhexedrine, 15
Prostanozol, 6
Xxxxxxxxx, 13
Pseudoephedrine, 12, 15
X
Xxxxxxxxxx, 6
X
XXX140, 6
Ractopamine, 6
Xxxxxxxxxx, 10 , 9
Xxxxxxxxxx, 7
X
X-23, 6
Xxxxxxxxxx, 9, 12
Xxxxxxxxxx, 9
Xxxxxxxxx xxxxxxxx receptor xxxxxxxxxx (XXXXx), 6
Xxxxxxxxxx, 15
Sermorelin, 8
Xxxxxxxxxxx, 15
Xxxxxxxxxxxx, 15
Somapacitan, 8
Xxxxxxxxxx, 8
Xxxxxxx, 19
Xxxxxxxxxxx, 7
Xxxxxxxxxxxxxx, 12
XX9009, 11
Xxxxxxxxxx, 11
Xxxxxxxxxx, 6
Xxxxxxxxxx, 6
Xxxxxxxxxx, 15
X
Xxxxxxxxxxx, 8
Xxxxxxxxx, 10
Xxxxxxxxx, 13
XX-500, 8
Xxxxxxxxxxxxx, 15
Terbutaline, 9
Xxxxxxxxxxx, 8
Xxxxxxxxxxxx, 10
Xxxxxxxxxxxx, 6
Xxxxxxxxxxxxxxxxxxxxx, 17
Xxxxxxxxxxxxxxxxxxxx, 6
Xxxxxxxxxxx, 15
Xxxxxxxxx, 12
Thymosin-154, 8
Xxxxxxxx, 6
Xxxxxxx, 19
Xxxxxxxxx, 12
Xxxxxxxxxx, 12
Xxxxxxxxxx, 10
Transforming growth xxxxxx xxxx (TGF-ß) xxxxxxxxxx inhibitors, 7
Xxxxxxxxxx, 6
Xxxxxxxxxxx, 9
Triamcinolone xxxxxxxxx, 18
Xxxxxxxxxxx, 12
Xxxxxxxxxxxxx, 11
Trimetoquinol, 9
Xxxxxxxxxxx, 8
Xxxxxxxxxxxxxx, 15
Xxxxxxxxxxx, 9
X
Xxxxxxxxxx (XXX-6548), 7
Vaptans, 12
Xxxxxxxx xxxxxxxxxxx growth xxxxxx (VEGF), 8
Xxxxxxxxxx, 9
Xxxxxxxxx, 13
X
Xenon, 7
Xxxxxxxxxxxxxx, 15
X
XX-11, 6
X
Xxxxxxx, 6
Xxxxxxxxxx, 6
XXXXXXX XXXXXXXXXXXXX KODEX
MEZINÁRODNÍ
STANDARD
PRO XXXXXXXXXXXX XXXXXXX
2023
Xxxxxxxxxxx standard xxx Terapeutické xxxxxxx
Xxxxxxxxxxx xxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx xxxxxxx&xxxx;x xxxxx Xxxxxxxxx xxxxxxxxxxxxxxx&xxxx;Xxxxxx&xxxx;xx závazným Mezinárodním xxxxxxxxxx&xxxx;xxxxxxxxxx xxxx xxxxxxx Xxxxxxxxx xxxxxxxxxxxxxxx programu. Xxx xxxxxxxx po xxxxxxxxxx se Signatáři, veřejnými xxxxxx x xxxxxxx xxxxxxxxxxx zúčastněnými xxxxxxxx.
Xxxxxxxxxxx xxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx xxxxxxx&xxxx;xxx poprvé xxxxxx v xxxx 2004 a nabyl xxxxxxxxx 1. xxxxx 2005. Xxxxxxxx xxx xxxxxxxx xxxxxxxxxxx, xxxxxx x účinností xx xxxxx 2009, xxxxxxx x xxxxxxxxx xx xxxxx 2010, xxxxxxx x xxxxxxxxx xx xxxxx 2011, xxxxxxxx x xxxxxxxxx xx xxxxx 2015, popáté x xxxxxxxxx od xxxxx 2018, pošesté x účinností od xxxxx 2019, xxxxxxx x účinností xx xxxxx 2021. Tato xxxxxxxxxx xxxxx xxxx xxxxxxxxx XX&xxxx;XXXX&xxxx;23. xxxx 2022 x je xxxxxx od 1. xxxxx 2023.
Vydala:
WADA
Stock Xxxxxxxx Xxxxx
800 Xxxxx Xxxxxxxx (Xxxxx 1700)
PO Xxx 120
Xxxxxxxx, Quebec
Canada X4X 1X7
Xxx: + 1 514 904 9232
Xxx: + 1 514 904 8650
X-xxxx: xxxx@XXXX-xxx.xxx
&xxxx;
XXXXX
|
XXXXX XXXX: ÚVOD, XXXXXXXXXX&xxxx;XXXXXX, XXXXXXXXXX&xxxx;XXXXXXXXXXXXX XXXXXXXXX&xxxx;X XXXXXXXX |
|
|
1.0 |
Xxxx x xxxxxxxxx |
|
2.0 |
Xxxxxxxxxx&xxxx;Xxxxxx |
|
3.0 |
Xxxxxxxx a xxxxxx xxxxx |
|
XXXXX ČÁST: XXXXXXXXX A POSTUP XXX XXXXXXXXX&xxxx;XX |
|
|
4.0 |
Xxxxxxxxx&xxxx;XX. |
|
5.0 |
Xxxxxxxxxx&xxxx;Xxxxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx xx&xxxx;XX |
|
6.0 |
Xxxxxx při xxxxxxxx xxxxxxx x&xxxx;XX |
|
7.0 |
Xxxxxx xxx xxxxxxxx&xxxx;XX |
|
8.0 |
Xxxxxxxxxxx xxxxxxxxxx x&xxxx;XX&xxxx;xx xxxxxx XXXX |
|
9.0 |
Xxxxxxxxx xxxxxxxxx |
|
XXXXXXX 1: Xxxxxxxxx xxxxxxx xxx xxxxxx 4.4 Kodexu |
|
ČÁST XXXXX: ÚVOD, USTANOVENÍ XXXXXX, MEZINÁRODNÍHO XXXXXXXXX X XXXXXXXX
1.0&xxxx;Xxxx x xxxxxxxxx
Xxxxxxxxxxx standard pro Terapeutické xxxxxxx&xxxx;xx xxxxxxxx&xxxx;Xxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxxxx xxxx xxxxxxx Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx.
Xxxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx xxxxxxx&xxxx;xx xxxxxxxx (x) xxxxxxxx, xxxxx xxxx být xxxxxxx, xxx xxxx xxxxxxx&xxxx;Xxxxxxxxxxxx výjimka (dále TV), xxx xxxxxxxx přítomnost Zakázané látky ve Vzorku Xxxxxxxxx&xxxx;xxxx&xxxx;Xxxxxxx&xxxx;xx&xxxx;Xxxxx o použití, Držení a/nebo Podání či Pokus x Podání Zakázané xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx Xxxxxxxxxx&xxxx;xxx&xxxx;xxxxxxxxxxxx&xxxx;xxxxx; (x) xxxxxxxxxx xxxxxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxxx&xxxx;xxxxxxxx xx xxxxxxxxxxx x&xxxx;XX&xxxx;x xxxxxx xxxxxxxxxx; (x) xxxxxx, xxxxx xx&xxxx;Xxxxxxxxx&xxxx;xxxxx x&xxxx;XX; (x) xxxxxx, xxxxx xx&xxxx;Xxxxxxxxx&xxxx;xxxxxx&xxxx;XX&xxxx;xxxxxxxx xxxxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxx&xxxx;x xxxxxxxxx xxxxx&xxxx;Xxxxxxxxxxxxxx organizací; (x) xxxxxx, xxxxx&xxxx;XXXX&xxxx;xxxxxxxxxxx xxxxxxx&xxxx;XX; x (x) xxxxxxxxxx x xxxxxx důvěrnosti, xxxxx xxxx aplikována x průběhu udělování TV.
Termíny xxxxxxxxx v xxxxx&xxxx;Xxxxxxxxxxxx xxxxxxxxx, xxxxx jsou xxxxxxxxxx x Xxxxxx, xxxx xxxxx xxxxxxxx. Xxxxxxx, xxxxx jsou xxxxxxxxxx v tomto xx jiném Mezinárodním xxxxxxxxx, xxxx xxxxxxxxx.
2.0&xxxx;Xxxxxxxxxx&xxxx;Xxxxxx
Xxxxxxxxxxx články Kodexu 2021 xx přímo xxxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx výjimky, xxx xx xxxxxx xxxxxxx xx samotný Kodex:
• Článek 4.4 Kodexu Xxxxxxxxxxxx xxxxxxx&xxxx;("XX")
•&xxxx;Xxxxxx 13.4&xxxx;Xxxxxx&xxxx;Xxxxxxxx xxxxxxxx se TV
3.0 Definice x xxxxxx xxxxx
3.1&xxxx;Xxxxx xxxxxxxxxx x Kodexu 2021, xxxxx xxxx xxxxxxx x&xxxx;Xxxxxxxxxxxx xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx xxxxxxx
XXXXX&xxxx;(XXXXX): Xxxx-Xxxxxx Xxxxxxxxxxxxxx xxx Xxxxxxxxxx System): xx xxxxxxx&xxxx;XXXX&xxxx;xxx xxxxxx xxxxxxxx xxxx xxxxxx xxxxxxxx xxx zadávání xxx, xxxxxx xxxxxxxx, xxxxxxx x hlášení, vytvořený xx xxxxx xxxxxxxxxxx xxxxxxx a WADA v jejich xxxxxxxxxxxxxxx činnostech, xx xxxxxxx s xxxxxxxxxxxx xxxxxxxx xxxxx.
Xxxx&xxxx;(Xxxxx): Xxxxx xxxxxxxxxxxx&xxxx;Xxxxxxx&xxxx;xxxxxxxxxxxxx xxxxxxxx, která xx řízena xxxxxx xxxxxxx (např. xxxxxxxxxx xxx, mistrovství xxxxx Xxxxxxxxxxx xxxxxxxx, Xxxxxxxxxxx xxx).
Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;(Xxxx-Xxxxxx Organization): WADA nebo Signatář, xxxxx xxxxxxxx xx xxxxxxx xxxxxxxx xxx xxxxxxxxxx, implementaci xxxx xxxxxxxxxxx jakékoli xxxxx xxxxxxx&xxxx;Xxxxxxxxx kontroly. Jedná xx xxxx. o Xxxxxxxxxxx olympijský xxxxx, Xxxxxxxxxxx xxxxxxxxxxxxx xxxxx, xxxx&xxxx;Xxxxxxxxxxxx xxxxxxxxxx akcí, xxxxx xxxxxxxxx&xxxx;Xxxxxxxxx&xxxx;x průběhu xxxxx&xxxx;Xxxx, Mezinárodní federace x&xxxx;Xxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx.
XXX:&xxxx;(Xxx Xxxxx xx Arbitration xxx Sport): Xxxxxxxx xxxx xxx xxxxx.
Xxxxxx&xxxx;(Xxxxxxxxxx): Xxxxxxxx, xxxxxxx&xxxx;Xxxxxx, xxxxxxxx xxxxxxx&xxxx;Xxxxxx&xxxx;(xx xxxxxxx xxxx xxxxx xxx xxxxx, xxxxx xx xxxxx xxxxxxx&xxxx;Xxxxx&xxxx;xxxxxxxx xxxxxxxx nebo xxxx mít xxxxxxxx xxx&xxxx;Xxxxxxxxx xxxxxx&xxxx;xxxx&xxxx;Xxxxxxxxx metodou nebo xxx xxxxxxxxx, xx xxxxxx se Xxxxxxxx xxxxx xxxx Xxxxxxxx xxxxxx nacházejí), xxxxx x xxx, xx xxxx&xxxx;Xxxxx&xxxx;xxxx xxxxxxxx kontrolu xxx Xxxxxxxxx látkou xxxx Zakázanou xxxxxxx xxxx nad xxxxxxxxx, xx xxxxxx xx&xxxx;Xxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx&xxxx;xxxxxxx, bude xxxxxxx&xxxx;Xxxxxx&xxxx;xxxxxxxxxx xxxxx xx&xxxx;Xxxxx, xxxxx xxxxxx o xxxxxxxxxxx&xxxx;Xxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx metody a xxxx x úmyslu xxxxxxx xxxxxxxx xxx xxxx xxxxxxxxx. K xxxxxxxx xxxxxxxxxxxxxxx pravidla, xxxxx jde xxxxx x&xxxx;Xxxxxx, xxxxxxx, xxxxxxxx xxxx xxxxxxxxx jakéhokoli xxxxxxxx, xx&xxxx;Xxxxx&xxxx;xxxxxxxx antidopingové xxxxxxxx, xxxxx xxxx&xxxx;Xxxxx&xxxx;xxxxxxxxx xxxxx, xxxxxxx prokáže, xx xxxxx xxxxxx&xxxx;Xxxxxx&xxxx;x xxxxxx x xxxxxxxx xx&xxxx;Xxxxxx&xxxx;xxx xxxxxxxxxx xxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxx. Bez xxxxxx xx cokoli xxxxxxxx x xxxx xxxxxxxx, xxxxx (xxxxxx elektronického xx xxxxxx xxxxxxx)&xxxx;Xxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx metody představuje vždy Držení pro Osobu, xxxxx xxxxx uskuteční.
[Poznámka x Xxxxxx: Xxxxx xxxx xxxxxxxx xx xxxxxxxx xxxxxxxxxxxx steroidů x xxxx Xxxxxxxxx xxxxxxxxx porušení, xxxxx Xxxxxxxxx xxxxxxxxx, xx xxxx xxxxxxxx někdo xxxx. V xxx xxxxxxx xxxx Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxx, xx x xxxx Sportovec xxxxx xxxxxxxx xxxxxxxx xxx xxxxx, xxxxx x xxxxxxxxxxxx steroidech x xxx v xxxxxx je xxxxxx. Xxxxxxx v xxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx x xxxxxx xxxxxxxxxx, xx které má xxxxxxx Xxxxxxxxx i xxxx xxxxxxx/xxxxxxxxx, xxxx Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxx, xx Xxxxxxxxx x xxxxxxxxxx v lékárničce xxxxx x xx xxx x xxxxxx xx xxxxxx. Samotný xxxxxx xxxxxx Xxxxxxxx xxxxx představuje xxx x xxxx Xxxxxx, x xxxx například xxxxxxx xxxxxxxx, obdrží xxx xxxxx xxxx xxxx je xxxxxx xx xxxxxx xxxxx xxxxx.]
Xxxxx&xxxx;(Xxxx): Xxxxxxx antidopingový Kodex.
Mezinárodní Xxxx&xxxx;(Xxxxxxxxxxxxx Xxxxx):&xxxx;Xxxx&xxxx;xxxx&xxxx;Xxxxxx, kterou xxxx Xxxxxxxxxxx xxxxxxxxxx xxxxx, Xxxxxxxxxxx xxxxxxxxxxxxx xxxxx, Mezinárodní xxxxxxxx,&xxxx;Xxxxxxxxxxx xxxxxxxx Akce nebo xxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxxx, xxxx&xxxx;Xxxx, na kterou xxxxx z xxxxxxxxx xxxxxxxxxx xxxxxxx xxxxxxxxx xxxxxxxxxxx.
Xxxxxxxxxxx xxxxxxxx&xxxx;(Xxxxxxxxxxxxx Xxxxxxxx): Xxxxxxxx, který přijala WADA na xxxxxxx&xxxx;Xxxxxx. Xxxxxxxxxx&xxxx;Xxxxxxxxxxxxx standardu (na xxxxxx od xxxxxx xxxxxxxxxxxxxx xxxxxxxxx, xxxxxxx xxxx procedur) xxxx xxxxxxxxxx x xxxxxx, xx xxxxxxx, xxxxx xxxx uvedeny v Mezinárodním xxxxxxxxx, byly uskutečněny xxxxx.&xxxx;Xxxxxxxxxxx xxxxxxxxx&xxxx;xxxxxxxx xxxxxxx&xxxx;Xxxxxxxxx xxxxxxxxx&xxxx;xxxxxx xxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxx.
Xxxx Xxxxxx&xxxx;(Xxx-xx-Xxxxxxxxxxx): Xxxxxxxx xxxxxx, xxxxx xxxx&xxxx;Xxx Xxxxxxx.
Xxxxxxxxx x xxxxxxxx&xxxx;(Xxxxxxx Xxxxxxxxxx): Xxxxxx pokrývající xxxxxx xxxxx mezi vyrozuměním xxxxx xxxxxx 5 Mezinárodního xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxx x výsledky nebo x xxxxxxx případech (xxxx.&xxxx;Xxxxxxxx xxxxx, Xxxxxxxxxx xxx Xxxxxxxxx, xxxxxxxxxxxx xxxxxxxxx x xxxxx xxxxxx) a xxxx xxxxx před xxxxxxxxxxx xxxxxxxx stanovenými x xxxxxx 5&xxxx;Xxxxxxxxxxxxx xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxx x xxxxxxxx, přes xxxxxxxx až xx xxxxxxx vyřešení xxxxxxx, xxxxxx ukončení řízení x xxxxx xxxxxxxx xxxx xx xxxxxx xxxxxxxx (xxxxx xxxx xxxxxxxx xxxxxx).
Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx&xxxx;(Xxxxxxxx Xxxx-Xxxxxx Xxxxxxxxxxxx): Xxxxxxx xx xxxxxxxx xxxxxx v každé xxxx, xxxxx mají xx xxxxxxx úrovni xxxxxxxx xxxxxxxxx a xxxxxxxxxxx xxxxxxxx a xxxxxxxxx antidopingová xxxxxxxx, xxxxxxxxx xxxxxx&xxxx;Xxxxxx, Nakládat x xxxxxxxx xxxxx x xxxx xxxxxx. Xxxxxxxx xxxx stanovení xxxxxx xxxxxxxxx xxxxxxxxxx xxxxxxx xx xxxxxx xxxxxx xxxxxx, xxx xxxxxxx subjektem bude Národní xxxxxxxxxx xxxxx&xxxx;xxxx xxxx xxxx xxx xxxxxxxx xxxxxxx.
Xxxxxxxxxxxx významných Xxxx&xxxx;(Xxxxx Xxxxx Organizations): Kontinentální xxxxxxxx&xxxx;Xxxxxxxxx xxxxxxxxxxxx výborů a xxxxxx xxxxxxxxxxxxx xxxxxxxxxx xxx xxxx sportů, xxxxx xxxxxx xxxx xxxxxx xxxxxx xxx xxxxxxxxxxxxx, regionální xx xxxxx&xxxx;Xxxxxxxxxxx Akci.
Podání (Administration): Xxxxxxxxxxx, xxxxxxxx, dohlížení, napomáhání xxxx xxxx podílení xx xx&xxxx;Xxxxxxx&xxxx;xxxx&xxxx;Xxxxxx&xxxx;x&xxxx;Xxxxxxx&xxxx;xxxxx&xxxx;Xxxxxx, x xx&xxxx;Xxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx. Xxxx xxxxxxxx xxxx xxxxxxxxxx xxxxxxxxx se Zakázanou xxxxxx&xxxx;xxxx&xxxx;Xxxxxxxxx xxxxxxx&xxxx;xxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxx x dobré xxxx ("xxxx xxxx") xxx xxxxxxxx x xxxxxxx xxxxxxxxxxxx xxxxx xx x jiným xxxxxxxxxxx xxxxxxxxxxx, x xxxx xxxxxxxxxx xxxxxxxxx xx&xxxx;Xxxxxxxxxx látkami, xxxxx xxxxxx xxxxxxxx xxx&xxxx;Xxxxxxxxx Xxxx Xxxxxx, pokud xx x xxxxxxx xxxxxxx xxxxxxxxx, že xxxx&xxxx;Xxxxxxxx látky nejsou xxxxxx xxx xxxxxxxx x xxxxxxx xxxxxxxxxxxx účely xxxx xxxx určeny xx xxxxxxx xxxxxxxxxxx xxxxxx.
Xxxxx&xxxx;(Xxxxxxx): Xxxxxxx xxxxxxx, xxxxx xxxxxxxxxxx významný xxxx v xxxxxxx xxxxxxx xxxxxxxxxxx xxxxxxxxx x porušení xxxxxxxxxxxxxxx xxxxxxxx. K xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxx na Pokusu o xxxxxxxx xxxx xxxxxxx, pokud Osoba od Pokusu ustoupí xxxxx, než xxx xxxxxxx xxxxx xxxxxxx, xxxxx se Pokusu neúčastní.
Pozitivní xxxxxxxxxxx xxxxx&xxxx;(Xxxxxxx Xxxxxxxxxx Finding): Xxxxxx x xxxxxxxxxx xxxxxxxxxxxx&xxxx;XXXX&xxxx;xxxx xxxx xxxxxxxxxx xxxxxxxxx&xxxx;XXXX, xxxxx xx xxxxx x&xxxx;Xxxxxxxxxxxx xxxxxxxxxx&xxxx;xxx xxxxxxxxxx identifikuje xx&xxxx;Xxxxxx&xxxx;xxxxxxxxxx&xxxx;Xxxxxxxx xxxxx&xxxx;xxxx xxxxxx&xxxx;Xxxxxxxxxx&xxxx;xx&xxxx;Xxxxxxx, nebo xxxxx prokazuje na Použití Xxxxxxxx metody.
Při Xxxxxxx&xxxx;(Xx-Xxxxxxxxxxx): Xxxxxx xx 23:59 x xxx xxxx&xxxx;Xxxxxxx, xxxxx se má Sportovec zúčastnit, xx konce Soutěže a xxxxxxx xxxxxx&xxxx;Xxxxxx, xxxx xx xx&xxxx;Xxxxxxx&xxxx;xxxxxx.&xxxx;XXXX&xxxx;xxxx xxx konkrétní xxxxx xxxxxxxx xxxxxxxxxxxx xxxxxxxx, jestliže Mezinárodní xxxxxxxx&xxxx;xxxxxxxx xxxxxxxxxxx odůvodnění, xx xxxx xxxxxxxx je xxx xxxx xxxxx xxxxxxxx. Xx xxxxxxx xxxxxxxxx&xxxx;XXXX&xxxx;xxxxx podle xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx všichni Organizátoři xxxxxxxxxx Xxxx&xxxx;x xxxxxxxxxx xxxxxx.
[Xxxxxxxx x Xxx Xxxxxxx: Xxx všeobecně xxxxxxxxxx xxxxxxxx xxxxxxx Xxx xxxxxxx xxxxxxxxx xxxxx xxxxxxxxxxx xxxx Xxxxxxxxx xx všech xxxxxxxx, xxxxxxxxx xxxx xxxxxxx xxxxxxxxxx mezi Xxxxxxxxx xxxxxxx xxxxxxxxxxx xxxxxxxx xxxxx xxx Xxxxxxxxx Xxx xxxxxxx, xxxxxxxxx neúmyslným Pozitivním xxxxxxxxxxx nálezům mezi Xxxxxxxxx během Xxxx x xxxxxx předcházet xxxxxxx potenciálních xxxxx xxxxxxxxx výkonu xx Xxxxxxxxxx xxxxx Mimo xxxxxx do xxxxxx Xxxxxxx.]
Xxxxxxx&xxxx;(Xxx): Xxxxx, xxxxxxxx, xxxxxx, xxxxxxx, xxxx xxxxxxxxx jakýmkoli xxxxxxxx&xxxx;Xxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx metody.
Rekreační Sportovec (Recreational Xxxxxxx): Xxxxxxx&xxxx;Xxxxx, kterou xxxxxxxx příslušná Národní antidopingová xxxxxxxxxx; za předpokladu, xx termín xxxxxx xxxxxxxxx xxxxxx&xxxx;Xxxxx, která xxxxx xxxx xxx xxxx xxxxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxx&xxxx;Xxxxxxxxxx Mezinárodní xxxxxx&xxxx;(xxx xx xxxxxxxxxx xxxxxx Xxxxxxxxxxx federací x xxxxxxx s Mezinárodním xxxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxx&xxxx;x Xxxxxxxxxxx) nebo Sportovcem Xxxxxxx xxxxxx&xxxx;(xxx jej definuje xxxxx&xxxx;Xxxxxxx xxxxxxxxxxxxx organizace v xxxxxxx x&xxxx;Xxxxxxxxxxxx xxxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxx&xxxx;x Xxxxxxxxxxx), která xxxxxxxxxxx xxxxxxxxx xxxx xx&xxxx;Xxxxxxxxxxx Xxxx&xxxx;x xxxxxxxx xxxxxxxxx xxxx xxxxx xxxx xxxxxxxx do xxxxxxxxxxx&xxxx;Xxxxxxxx xxx Testování či xxxxxx xxxxxxxx informací o xxxxx xxxxxx vedeného xxxxxxxxx Xxxxxxxxxxx federací xxxx&xxxx;Xxxxxxx xxxxxxxxxxxxxx xxxxxxxxxx.
[Xxxxxxxx x Xxxxxxxxxxx Xxxxxxxxx: Xxxxxx "xxxxxxxx kategorie" xx xxxxxxxx xxxxxx, xxxxx xx omezena xx xxxxxxxxx xxxx xxxxxx xxxxxxxxx.]
Xxxxxx&xxxx;(Xxxxxxxxxx Xxxx):&xxxx;Xxxxxx xxxxxxxxxxxxxx&xxxx;Xxxxxxxx xxxxx&xxxx;x&xxxx;Xxxxxxxx xxxxxx.
Xxxxxx&xxxx;(Xxxxxxxxxxx): Xxxxxxxxxx xxxxx, xxxxx, xxx xxxx xxxxxxxxxx xxxxxxxxx utkání. Například xxxxxxxxxxxx xxxxx xxxx xxxxxxxxxx xxxxxx xxxx xx 100 xxxxx x xxxxxxxx. X xxxxxxxxx závodů x xxxxxx xxxxxxxxxxx xxxxxx, xxx xx ceny xxxxxxx denně nebo x xxxxxx xxxxxxxxxxx, xx xxxxxx xxxx&xxxx;Xxxxxxx&xxxx;x&xxxx;Xxxx&xxxx;xxxxxx xxxxx pravidel příslušné Xxxxxxxxxxx xxxxxxxx.
Xxxxxxxxx&xxxx;(Xxxxxxx): Jakákoli Osoba, xxxxx xxxxxxx ve xxxxxx xx xxxxxxxxxxx xxxxxx (xxxxxx xxxxxxxx xxxxxxxxxx Xxxxxxxxxxx xxxxxxxx) xxxx xx národní xxxxxx (xxxxxx definují xxxxxxxxxx&xxxx;Xxxxxxx xxxxxxxxxxxxx organizace). Antidopingová xxxxxxxxxx&xxxx;xx xxxx xxxx xxxxxxxxxx xxx aplikaci xxxxxxxxxxxxxxx xxxxxxxx xx&xxxx;Xxxxxxxxx, xxxxx není Sportovcem xxxxxxxxxxx xxxxxx ani Sportovcem xxxxxxx xxxxxx, a xxx xx něho xxxxxxxx definici "Xxxxxxxxx". Xxx&xxxx;Xxxxxxxxx, xxxxx xxxxxx&xxxx;Xxxxxxxxx xxxxxxxxxxx xxxxxx&xxxx;xxx&xxxx;Xxxxxxxxx národní xxxxxx, xxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx xxxxxxx Xxxxxxxxx&xxxx;xxxx neprovádět xxxxx&xxxx;Xxxxxxxxx; xxxxxxxxxxxx&xxxx;Xxxxxx&xxxx;xxx xxxxx xxxxx&xxxx;Xxxxxxxxxx látek; požadovat xxxxxxx xxxxxxxxx x xxxxx xxxxxx nebo xxxxxxxxxxx xxxxx; xxxxxxxxxxx xxxxxx&xxxx;XX. Xxxxx xxxxx xxxxx podle xxxxxx 2.1, 2.3 xxxx 2.5 k porušení xxxxxxxxxxxxxxx xxxxxxxx&xxxx;Xxxxxxxxxx, x xxxxx se Antidopingová organizace rozhodla, xx xxxxxxx svou xxxxxxxx testovat, x xxxxx soutěží xxx xxxxxxxxxxx nebo xxxxxxx xxxxxx, xxx musí xxx xxxxxxxxx&xxxx;Xxxxxxxx&xxxx;xxxxxxxxx v Kodexu. Xxx účely xxxxxx 2.8 a 2.9 x xxxxx antidopingové xxxxxxxxxxxxxx a Vzdělávání, každá Osoba, xxxxx xxxxxxx xx xx xxxxxxx&xxxx;Xxxxxxx&xxxx;xx xxxxxx, xxxxx xxxxx do xxxxxxxxx kteréhokoli Signatáře, xxxxx xxxx jiné xxxxxxxxx xxxxxxxxxx, která přijala Kodex, xx xxxxxxxxxx xx&xxxx;Xxxxxxxxx.
[Xxxxxxxx xx Xxxxxxxxx: Xxxxxxxxxxx, xxxxx se účastní xxxxxx, mohou spadat xx xxxxx x xxxx xxxxxxxxx: 1)&xxxx;Xxxxxxxxx xxxxxxxxxxx úrovně, 2) Xxxxxxxxx xxxxxxx xxxxxx, 3) jednotlivci, xxxxx xxxxxx Xxxxxxxxx mezinárodni xxxx xxxxxxx xxxxxx, xxx nad nimiž xx xxxxxxxx vykonávat xxxxxxxx Mezinárodní xxxxxxxx xxxx Národní xxxxxxxxxxxxx xxxxxxxxxx, 4) Xxxxxxxxx Xxxxxxxxx a 5) xxxxxxxxxxx, xxx xxxxx xxxxx Xxxxxxxxxxx xxxxxxxx xxx Xxxxxxx antidopingová xxxxxxxxxx xxxxxxxxxx xxxxxxxx xxx xx xxxxxxxxxx xxxxxxxx xxxxxxxxx. Xx xxxxxxx Sportovce xxxxxxxxxxx x xxxxxxx xxxxxx xx xxxxxxxx xxxxxxxxxxxxx xxxxxxxx Xxxxxx x xxxxxxxx xxxxxxxxxx sportu xxxxxxxxxxx a xxxxxxx xxxxxx, xxxxx xxxxx xxxxxxxxx x xxxxxxxxxxxxxxx xxxxxxxxxx Mezinárodních federací x Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxx.]
Xxxxxxxxx xxxxxxxxxxx xxxxxx&xxxx;(Xxxxxxxxxxxxx-Xxxxx Xxxxxxx):&xxxx;Xxxxxxxxx, xxxxx xx xxxxxxx sportu na xxxxxxxxxxx xxxxxx, xxx xx xxxxxxxxxx každou Xxxxxxxxxxx federací xx xxxxx s Mezinárodním xxxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxx&xxxx;x&xxxx;Xxxxxxxxxxx.
[Xxxxxxxx xx Sportovci xxxxxxxxxxx xxxxxx: X souladu x Mezinárodním xxxxxxxxxx xxx Testování x Xxxxxxxxxxx xxxx Xxxxxxxxxxx xxxxxxxx xxxxxxxx xxxxxxxx xxxxxxxx, xxxxx použije xx xxxxxxxxxxx Xxxxxxxxx xxxx Xxxxxxxxx mezinárodní xxxxxx, xxxx. podle xxxxxxxxx, účastí na xxxxxxxxxxx Xxxxxxxxxxxxx xxxxxx, xxxxx xxxx xxxxxxx xxx. Xxxx xxxx xxxx xxxxxxxx xxxxxxxxx xxxxxx x xxxxxxxx xxxxxx, xxx Sportovci xxxxx xxxxxx a xxxxxx zjistit, xxx xxxxx klasifikováni xxxx Xxxxxxxxx xxxxxxxxxxx xxxxxx. Xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx účast xx xxxxxxxx Xxxxxxxxxxxxx xxxxxx, xxxx Xxxxxxxxxxx federace Xxxxxx xxxxxx Mezinárodních xxxx xxxxxxxxx.]
Xxxxxxxxx xxxxxxx xxxxxx&xxxx;(Xxxxxxxx-Xxxxx Athlete): Sportovci, xxxxx xx xxxxxxx xxxxxx xx národní xxxxxx, xxx xx xxxxxxxxxx xxxxxx&xxxx;Xxxxxxx xxxxxxxxxxxxxx organizací ve xxxxx s Mezinárodním xxxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxx&xxxx;x&xxxx;Xxxxxxxxxxx.
Xxxxxxxxxxxx xxxxxxx&xxxx;("XX") (Xxxxxxxxxxx Use Xxxxxxxxx):&xxxx;Xxxxxxxxxxxx výjimka umožňuje Sportovci se xxxxxxxxxx xxxxxxxxxxx Xxxxxx&xxxx;Xxxxxxxxx látku nebo Zakázanou xxxxxx, ale xxxxx xxxxx, xxxx-xx xxxxxxx xxxxxxxx stanovené x xxxxxx 4.4 x x&xxxx;Xxxxxxxxxxxx standardu pro Terapeutické výjimky.
Testování (Testing): Xxxxx xxxxxxx&xxxx;Xxxxxxxxx xxxxxxxx&xxxx;xxxxxxxxxx xxxxxxxxx xxxxx, xxxxx&xxxx;Xxxxxx, xxxxxxxxx se Vzorkem a xxxxxxxxx&xxxx;Xxxxxx&xxxx;xx xxxxxxxxxx.
Xxxxxxxxxx&xxxx;(Xxxxxxxxx): Xxxxxxxxxx xxxxxx, xxxxx xxxxxx xx xxxxxxx xxxxxxx x xxxxxxxx xxxxxx, xxxxx xxxxxxxx x xxxxxx xxxxxxxxxxx xxxxx a xxxxxxxxxxx xxxxxxxxx i xxxxxxxxxxx xxxxxxx.
Xxxxxx&xxxx;(Xxxxxx xx Xxxxxxxx): Xxxxxxxx biologický xxxxxxxx xxxxxxxx xx xxxxxx&xxxx;Xxxxxxxxx kontroly.
[Poznámka ke Xxxxxx: Někdy se xxxxx, xx xxxxx Xxxxxx xxxx porušuje xxxxxxxx xxxxxxxx xxxxxxxxxxxx xxxx kulturních xxxxxx. Xxxx xxxxxxxxx, xx xxx xxxxxx xxxxxxx xxxxxxxxxx žádný xxxxxx.]
XXXX&xxxx;(Xxx Xxxxx Anti-Doping Xxxxxx): Xxxxxxx xxxxxxxxxxxxx xxxxxxxx.
Xxxxxxxx xxxxx&xxxx;(Xxxxxxxxxx Substance): Xxxxxxxx xxxxx xxxx xxxxxxx xxxxx xxxxxxx v Seznamu.
Zakázaná xxxxxx&xxxx;(Xxxxxxxxxx Xxxxxx): Xxxxxxxx xxxxxx xxxxxxx v Seznamu.
3.2 Definované xxxxx x&xxxx;Xxxxxxxxxxxxx xxxxxxxxx&xxxx;xxx xxxxxxx soukromí x xxxxxxxx xxxxx
Xxxxxx xxxxx:&xxxx;Xxxxx, xxxx xxxx včetně Citlivých xxxxxxxx xxxxx, týkající xx&xxxx;Xxxxxxxxx&xxxx;xxxx xxxx&xxxx;Xxxxx, jejichž xxxxxxxxx byla xxxxxxxxx xxxx je xxxxx xx xxxxxxxx, x xxxxxxx xxxxx jsou Zpracovávány výhradně x xxxxxxxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx Xxxxxxxxxxxxx organizace.
[Poznámka x&xxxx;Xxxxxxx xxxxxx:&xxxx;Xxxxxx xx, xx&xxxx;Xxxxxx xxxxx&xxxx;xxxxxxxx xxxx xxxx xxxxx xxxxxxxx xx jména Xxxxxxxxx, xxxx xxxxxxxx, xxxxxxxxxxx xxxxx x sportovních xxxxxxxx, místa xxxxxx, xxxxxxxxxxx TV (xxxx-xx xxxxxx), výsledků antidopingových xxxxx x xxxxxxxx xxxxxxxx xxxxxx (xxxxxx xxxxxxxxxxxxxxx xxxxxx, xxxxxxxx x sankcí). Osobní údaje také xxxxxxxx osobní a xxxxxxxxx informace xxxxxxxx xx jiných Osob, xxxx xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxx Xxxx, xxxxx xxxxxxx xx Sportovcem, xxxxxxxx xxx xxxx xx xxxxxxxx v xxxxx Xxxxxxxxxxxxx xxxxxxxx. Xxxxxx xxxxxxxxx xxxx xxxxx xxxxxxxxxx za Osobní xxxxx&xxxx;x jsou tímto Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xx celou dobu xxxxxx&xxxx;Xxxxxxxxxx, xxx ohledu xx xx, xxx xx příslušný xxxxxxxxxxx xxxxx zapojen xx xxxxxxxxxxxxxx xxxxxx.]
Xxxxxxxxxx&xxxx;(x xxxxx xxxxx&xxxx;Xxxxxxxxxx,&xxxx;Xxxxxxxxxxxx&xxxx;xxxx.): Xxxxxxxxxxxxx, xxxxxxx, xxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxxxxx, xxxxxx, změna, xxxxxx xxxx xxxx xxxxxxxxx&xxxx;Xxxxxxxx xxxxx.
3.3&xxxx;Xxxxxxxxxx xxxxx, xxxxx xxxx xxxxxxxxxx xxx&xxxx;Xxxxxxxxxxx xxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx výjimky
Komise xxx xxxxxxxxxxxx xxxxxxx ("XXX")&xxxx;(Xxxxxxxxxxx Xxx Xxxxxxxxx Xxxxxxxxx xx "TUEC"): Orgán xxxxxxxxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxx&xxxx;xx xxxxxx xxxxxxxxxx xxxxxxx x&xxxx;XX.
XXX XXXX&xxxx;(XXXX TUEC): Xxxxx xxxxxxxxxx&xxxx;XXXX&xxxx;xx účelem xxxxxxxxxxxxx xxxxxxxxxx xxxxxx&xxxx;Xxxxxxxxxxxxxxx organizací o TV.
Terapeutický (Therapeutic): Xxxxxxxxxx xx x xxxxx xxxxxxxxxxx xxxxx xxxxxxxxx prostředky xxxx xxxxxxxx; xxxx xxxxxxxxxxx xx xxxxxxxxxxxx xxxxxxxxx.
3.4&xxxx;Xxxxxx xxxxx
3.4.1&xxxx;Xxxxxxxxx text Mezinárodního xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx xxxxxxx&xxxx;xxxx xxxxxxxxxx x xxxxxxxxxx x francouzštině. X případě jakýchkoli xxxxxxx mezi xxxxxxxxx x xxxxxxxxxxxx xxxxx xxxxx anglická verze.
3.4.2 Stejně xxxx&xxxx;Xxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxx xxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx xxxxxxx&xxxx;xxxxxxxxxx x ohledem na xxxxxx xxxxxxxxxxxxxxx, lidská xxxxx a xxxxx xxxxxxxxx xxxxxx zásady. X x xxxxx xxxxxx bude xxxx xxxxxxxx x xxxxxxxxx.
3.4.3&xxxx;Xxxxxxxx xxxxxxxxxxx xxxxx xxxxxxxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx xxxxxxx&xxxx;xxxx xxxxxxx x xxxxxx xxxxxxxxxxxx.
3.4.4&xxxx;Xxxxx xxxx xxxxxxxxx xxxxx, xxxxxx xx xxxxx x xxxxxx xxxx xxxxxx xx xxxxx x xxxxxx&xxxx;Xxxxxxxxxxxxx standardu pro Terapeutické xxxxxxx.
3.4.5&xxxx;Xxxxxx "xxx" xxxxxxx x&xxxx;Xxxxxxxxxxxx xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx xxxxxxx&xxxx;xxxxxxxxxx xxx, xxxxx není xxxxxxx xxxxx.
3.4.6&xxxx;Xxxxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx xxxxxxx&xxxx;xxxx xxxxxx xxxxxxx xxxxxxxx jako zbytek Mezinárodního xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx xxxxxxx.
XXXXX ČÁST: XXXXXXXXX X XXXXXX XXX XXXXXXXXX TV
4.0 Udělování TV
Sportovec, xxxxx x&xxxx;Xxxxxxxxxxxxxx&xxxx;xxxxxx xxxxxxxxx xxxxxx&xxxx;Xxxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxxx xxxxxx, xxxx před Použitím nebo Držením xxxxxxxx xxxxx nebo metody xxxxxxx x&xxxx;XX, pokud xxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxxx xxxxxxx x&xxxx;XX&xxxx;xx xxxxxxx platností podle xxxxxx 4.1. V xxxx případech xxxx xxx xxxxxxx podmínky xxxxxx 4.2.
[Poznámka k xxxxxx 4.0: Mohou xxxxxx xxxxxxx, kdy xx Xxxxxxxxx nemocný x xxxxx nebo xx x xxxxxx Xxxxxxxxx xxxxx xxxx Xxxxxxxxx xxxxxx xxxxxxx, xxx xx xx xxxx xxxxxx xxxxxxxxx xxxxxxxxxxxxx pravidla. X xxxxxxx xxxxxxx nevyžaduje xxxxxx xxxxxxxxx xxxxxxx/xxxxxx XX x xxxx xxxxxxxxxx&xxxx;XX&xxxx;x xxxxxxx platností.]
4.1 Na xxxxxxx&xxxx;XX&xxxx;xx xxxxxxx xxxxxxxxx xxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxx x&xxxx;XX&xxxx;xxx&xxxx;Xxxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxxx xxxxxx&xxxx;xxxx, co dotyčnou xxxxx xxxx xxxxxx&xxxx;xxxx&xxxx;xxxx&xxxx;xxx x držení.
Sportovec může x&xxxx;XX&xxxx;xxxxxxx xx xxxxxxx xxxxxxxxx (xxxx však stále xxxxxxxx xxxxxxxx článku 4.2), pokud xxxxx xxxxxxx z xxxxxxxxxxxxx xxxxxxx:
x)&xxxx;Xxxxxxx xxxxxxx neodkladné xxxxx nebo xxxxx xxxxxxxx xxxxxxxxxxx xxxxx;
x)&xxxx;Xxxxx xxxxxxxxxx okolnostem nebyl xxxxxxxx času xx xxxxxxxxxxxx, aby Sportovec podal žádost x&xxxx;XX&xxxx;(xxxx XXX situaci xxxxxx) xxxx xxxxxxx&xxxx;Xxxxxx;
x)&xxxx;X xxxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxxx xxxx disciplín xx národní xxxxxx&xxxx;Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx Xxxxxxxxx&xxxx;xxxxxxxxxx xxx nepožadovala, xxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxx x potenciální TV (viz xxxxxxxx x xxxxxx 5.1);
x)&xxxx;Xxxxx xx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx odebrat Vzorek od Sportovce, xxxxx xxxx&xxxx;Xxxxxxxxxx mezinárodní xxxxxx&xxxx;xxxx&xxxx;Xxxxxxxxxx národní xxxxxx, x xxxxx&xxxx;Xxxxxxxxx&xxxx;x&xxxx;Xxxxxxxxxxxxxx&xxxx;xxxxxx xxxxxxx&xxxx;Xxxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxxx xxxxxx,&xxxx;Xxxxxxxxxxxxx organizace musí xxxxxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxx x&xxxx;XX&xxxx;xx zpětnou xxxxxxxxx; xxxx
x)&xxxx;Xxxxxxxxx Xxxxxx Xxxx Soutěž z Terapeutických důvodů Zakázanou látku, xxxxx xx zakázána xxxxx&xxxx;Xxx Xxxxxxx.
[Xxxxxxxx x xxxxxx 4.1: Xxxxxxx xxxxx x xxxxxxx xxx XX se xxxxxxx xxxxxxxxx xxxxxxxxx, xx xxxx XX xxxxxxxx xxxxxxx; xxxxxxx xx, xx xxxxxx Xxxxxxxxx xxxx být xxxxxxxxxxx xxxxx xxxxxx 4.2, xxx se xxxxxxxx, xxx xxxx xxxxxxx xxxxxxxxx xxxxxxxx XX.]
[Xxxxxxxx k článku 4.1 c), x) x x): X xxxxxxx, xxx xx xx xxxxxx Xxxxxx xxxxx žádost o XX xx xxxxxxx xxxxxxxxx, xx Xxxxxxxxxx xxxxxxx xxxxxxxxxx, xxx xx nechali xxxxxxxxx xxxxxxxxx xxxxxxxxxxx x xxxx připraveni prokázat xxxxxxx podmínek pro XX stanovených x xxxxxx 4.2.]
[Xxxxxxxx x xxxxxx 4.1 x): Xxxxx xx xxxxx xxxxxxx, xxx Xxxxxxxxx x&xxxx;Xxxxxxxxxxxxxx&xxxx;xxxxxx Xxxxxxx Mimo Xxxxxx látku, která xx zakázána xxxxx Xxx Soutěži, xxx xxxxxxxx xxxxxx, že xxxxx xxxxxxx Při Xxxxxxx x xxxxxx xxxx.
X xxxxxxxx situacích xxxx Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxx Xxxxxxxxx xxxxxxx x XX xx xxxxxxx platností (xxxxx Xxxxxxxxx xxxxxxxxx x XX xxxxxx). Xxxx xxxx xxxxxxx x xx, xxx Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx předem xxxxxxxxx xxxxxxx x XX, které xxxxxx xxx xxxxx.]
4.2&xxxx;Xxxxxxxxx&xxxx;xxxx být xxxxxxx&xxxx;XX, xxxxx (x xxxxx xxxxx) xxxx xxxxxxxx, při uvážení xxxxxxxxxxxxxxxx, že xx xxxxxxx každá x xxxxxxxxxxxxx xxxxxxxx:
x)&xxxx;Xxxx&xxxx;Xxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx&xxxx;xx xxxxx x xxxxx diagnostikovaných zdravotních xxxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxxxxx xxxxxx.
[Xxxxxxxx k xxxxxx 4.2 x): Xxxxxxx Xxxxxxxx xxxxx xxxx Xxxxxxxx xxxxxx xxxx xxx xxxxx xxxxxxxx nezbytného diagnostického xxxxxxxxx xxx xxxxxxxx xxxxxx.]
x)&xxxx;Xxxxxxxxxxxx&xxxx;Xxxxxxx Xxxxxxxx látky nebo Zakázané xxxxxx&xxxx;x xxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxx xxxxx xxxx xxxxxxx xxxxxx&xxxx;Xxxxxxxxx, xxx xxxx xxx očekávat xxxxxxxxxx xx xxxxxxxxxx xxxxxxxxxxx xxxxx xxxxxxxx xx léčbě xxxxxxxxxxx xxxxxx.
[Xxxxxxxx k článku 4.2 x): Xxxxxxxx xxxxxxxxx stav Sportovce xxxx xxxxx xxxxx xxxxxxxxxxxx. Normální xxxxxxxxx xxxx xxx konkrétního Xxxxxxxxx je xxxx xxxxxxxxx xxxx, ale xxx xxxxxxxxxxx potížích, xxxxx xxxxxx Xxxxxxxxx xxxx o XX.]
x)&xxxx;Xxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx&xxxx;xx xxxxxxxxxxx xxxxxx zdravotních xxxxxx x xxxxxxxxxx xxxxx xxxxxxxxxx xxxxxxxx&xxxx;Xxxxxxxxxxxx&xxxx;xxxxxxxxxxx.
[Xxxxxxxx x xxxxxx 4.2 x): Xxxxx xxxx xxxxxxxxx, xxxx xxxx zvolená xxxxx xxxxxxxxxxxx, xxxx. xx xxxxxxx xxxxxxxxxx, xxxxxxx xxxxxxxxxx účinků xxxx xxxxxx xxxxxxxxxx xxxxxxxxxx, včetně, xx-xx xx relevantní, xxxxxxxxxxx xxxxxxxxxx xxxxxxxx praxe x xxxxxxxx xxxxxxxx x xxxxx. Xxxx xxxx xxxx nutné xxxxxxxxx xxxxxxxxx alternativy xxxx xxxxxxxx Xxxxxxxx xxxxx xxxx Xxxxxxxx xxxxxx.]
x)&xxxx;Xxxxxxx xxxxxxx&xxxx;Xxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx&xxxx;xxxxxx xxx xxxxxxxxx, xxxxx xxxx xxxxxx, xxxxxxxxxx&xxxx;Xxxxxxx&xxxx;(xxx&xxxx;XX) xxxxx nebo xxxxxx, xxxxx xxxx x xxxx xxxxxxxx&xxxx;Xxxxxxx&xxxx;xxxxxxxx.
[Xxxxxxxx x článku 4.2: Xxxxxxxxx WADA x xxxxxx "Xxxxxxxx xxxxxxxxx xxx xxxxxxxxxxx x XX", xxxxxxxx xx xxxxxxxx xxxxxxxxx XXXX, xx se měly xxxxxxxx, xxx se xxxxxxxxx xxxxxxxxxx xxxxxx xxxxxxxx, xxxxx xxx x xxxxxxxxx xxxxxxxxx xxxxxx.
Xxxxxxx XX xx xxxxxxxx xxxxx xx xxxxxxx podmínek xxxxxxxxxxx x xxxxxx 4.2. Xxxxxxxxxxxx, zda xx Xxxxxxxx látka xxxx Xxxxxxxx xxxxxx xxxxxxxx xxxxxxxxxxxx xxxx xxxxxxxxxxxxxx, xxxx xxx je xxxx Xxxxxxx xxxxxxx xx xxxxx jurisdikcích.
Pokud XXX Xxxxxxxxxxx xxxxxxxx xxxx Organizátora významné Xxxx rozhoduje, xxx xxxxx xxxx neuznat XX xxxxxxxxxx xxxxx Xxxxxxxxxxxxxx xxxxxxxxxx (viz xxxxxx 7), a xxxxx XXXX xxxxxxxxxxx xxxxxxxxxx x xxxxxxx (xxxx xxxxxxxxx) XX (xxx xxxxxx 8), xxxxxxxx xxxx stejný xxxx x případě xxxxxxxxxx žádosti x Xxxxxxxxxxxxx xxxxxxx Xxxxxx xxx XX podle xxxxxx 6, tj., xxxxxxxx Xxxxxxxxx xxx xxxxxxx pravděpodobnosti, xx xx xxxxxxx každá x xxxxxxxx xxxxxx 4.2?]
4.3&xxxx;Xx xxxxxxxxxxx okolností x xxx xxxxxx xx xxxxxxxx xxxx xxxxxxxxxx tohoto Mezinárodního standardu pro Terapeutické xxxxxxx&xxxx;xxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxx o schválení Terapeutického Použití Xxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx&xxxx;xx xxxxxxx xxxxxxxxx, které xx bude xxxxxxx, xxxxx xx x xxxxxxx na xxxx Xxxxxx xxxx zjevně xxxxxxxxxxxxx&xxxx;XX&xxxx;xx zpětnou platností xxxxxxxx. U Sportovců xxxxxxxxxxx xxxxxx&xxxx;x&xxxx;Xxxxxxxxx xxxxxxx xxxxxx xxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxx xxxxxxx x&xxxx;XX&xxxx;xx xxxxxxx xxxxxxxxx xxxxx xxxxxx článku xxxxx x xxxxxxxxxx xxxxxxxxx&xxxx;XXXX&xxxx;(x&xxxx;XXXX&xxxx;xxxx podle svého xxxxxxxxxxx xxxxxxx x xxxxxxxxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxxx, xxxx xxx xxxxxxxxx).
X&xxxx;Xxxxxxxxx, kteří xxxxxx&xxxx;Xxxxxxxxx mezinárodní úrovně nebo Sportovci xxxxxxx xxxxxx, xxxx xxxxxxxxx&xxxx;Xxxxxxxxxxxxx organizace vyhovět xxxxxxx x&xxxx;XX&xxxx;xx xxxxxxx xxxxxxxxx xxxxx xxxxxx xxxxxx xxx předchozí xxxxxxxxxx x&xxxx;XXXX;&xxxx;XXXX&xxxx;xxxx xxxx kdykoli xxxxxxxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxx&xxxx;XX&xxxx;xx xxxxxxx xxxxxxxxx xxxxx xxxxxx xxxxxx xxxxxxxxxx x xxxx xxxxx svého xxxxxxxxxxx xxxxxxx x xxxxxxxxxxx xxxxxxxxx, xxxx xxx xxxxxx. Xxxxx xxxxxxxxxx rozhodnutí xxxxxxxxx&xxxx;XXXX&xxxx;x/xxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxx tohoto článku xxxxx vznést xxxxxxx xxxxx xxxxxx o xxxxxxxx antidopingového xxxxxxxx xxx xxxxxxxxxxxxxxx xxxxxxxx, xxx xxxxx.
Xxxxxxx xxxxxxxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxx xxxxxx xxxxxx 4.3, ať xx xxxxxxxxxx, nebo zamítnutí TV, xxxx xxx xxxxxxxxx xxxxxxxxxxxxxxx&xxxx;XXXXX&xxxx;x xxxxxxx x xxxxxxx 5.5.
[Poznámka x xxxxxx 4.3: Aby xx xxxxxxxx xxxxxxxxxxxx, xxxx xxx xxxxx xxxxxx 4.3 uděleno xxxxxxxxx xx xxxxxxx xxxxxxxxx, x xxxx xxxxxx splněny xxxxxxxx x xxxxxx 4.2 (xxxxxx xxxxxxx xxxxxx xxxxxxxx xxxx xxx xxxxxxxxxx xxxxxxxxxx). Xxxx xxxxx xxxxxxxxxx faktory xxxxx patřit např. xxxxxx, xxxx Sportovec xxxxxxxxx x XX xxxxxx; xxxxxxxxxx Xxxxxxxxx; xxxxxxxx, xxxxx Xxxxxxxxx xxxxxxx získal; xxx Xxxxxxxxx deklaroval Xxxxxxx xxxxx xxxx metody xx xxxxxxxx Xxxxxxxxx xxxxxxxx; x xxxxxxx xxxxxxxx XX Xxxxxxxxx. Xxx xxxx xxxxxxxxxxx xx může XXXX xxxxx xxxxx uvážení xxxxxxx se xxxxxx (xxxxx)&xxxx;XXX XXXX.]
5.0&xxxx;Xxxxxxxxxx&xxxx;Xxxxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx xx&xxxx;XX
5.1&xxxx;Xxxxxx 4.4 Kodexu specifikuje x) xxxxx&xxxx;Xxxxxxxxxxxxx organizace má xxxxxxxx xxxxxxxxxx x&xxxx;XX; b) xxx by xxxx xxx xxxx xxxxxxxxxx x&xxxx;XX&xxxx;xxxxxxxx x xxxxxxxxxxxx xxxxxx&xxxx;Xxxxxxxxxxxxxxx xxxxxxxxxxxx; a x) xxx xxxxx xxx rozhodnutí x&xxxx;XX&xxxx;xxxxxxxxxxxxx x/xxxx jak xx xxxxx nim xxx xxxxxxx.
[Xxxxxxxx x bodu 5.1: Viz xxxxxxx 1 - postupový xxxxxxx shrnující xxxxxxxx xxxxxxxxxx xxxxxx 4.4 Xxxxxx.
X případech, kdy xxxxxxxxx a priority xxxxxxx xxxxxxxx vedou Xxxxxxx xxxxxxxxxxxxxx xxxxxxxxxx x xxxx, xxx xxxxxxxxxxxxxxx určité sporty xxxx xxxxxxxxxx xxxx xxxxxx při xxxxxxxxx Xxxxxxxxx (xxx xx xxxxxxxxxxx dle xxxxxx 4.4.1 Mezinárodního xxxxxxxxx xxx Xxxxxxxxx a Xxxxxxxxxxx), Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx může xxxxxxxxx xxxxxxxxx xxxxxx xxxxxxx x XX Xxxxxxxxx x některých xxxxx xx všech neprioritních xxxxxx nebo disciplín, xxx v tom xxxxxxx xxxx povolit xxxxxxx takovému Xxxxxxxxx, xxxxxxx je xxxxxxxx xxxxxxx Vzorek, žádat x XX se xxxxxxx xxxxxxxxx. Národní xxxxxxxxxxxxx organizace by xxxx, ku xxxxxxxxx Xxxxxxxxx, xxxxxxx xx xx xxxx, xxxxx xxxxxx xxxxxxxxxx na xxxxx webových xxxxxxxxx.
Xxxxxx 4.4.2 Xxxxxx xxxxxxxxxxx xxxxxxxxx Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxx x XX v xxxxxxx Xxxxxxxxx, xxxxx xxxxxx Xxxxxxxxx xxxxxxxxxxx úrovně. X xxxxxxx xxxxx xxxxxxx xxxx, xxxxx Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx xx xxxx xxxxxxxxx xxxxxx x XX Xxxxxxxxx, xxxx není Xxxxxxxxxx xxxxxxxxxxx xxxxxx, xxxxxxxx WADA. Rozhodnutí XXXX xxxx konečné x xxxxx xx xxxxx xxxx xxxxxxx.]
5.2&xxxx;Xxx xxxxxxxxx xxxxxxxxxxx, když Národní xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxx&xxxx;Xxxxxxxxx TV, xxxx&xxxx;XX&xxxx;xx platná xx xxxxxxx xxxxxx v xxxxxxxxx měřítku x xxxxxx být formálně xxxxxx xxxxxx&xxxx;Xxxxxxxxx antidopingovými xxxxxxxxxxxx&xxxx;xxxxx xxxxxx 7.0 (xxxx. pokud xxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxx&xxxx;XX&xxxx;xxxx&xxxx;Xxxxxxx xxxxxxxxxxxxxx xxxxxxxxxx&xxxx;x xxx xxxx trénuje xxxx xxxxxxx v xxxx xxxx&xxxx;Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx, xxxx tato TV platná, xxxxx xxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxxx takovou jinou Národní xxxxxxxxxxxxxx xxxxxxxxxx).
5.3&xxxx;Xxxxx&xxxx;Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx, Xxxxxxxxxxx federace xxxx&xxxx;Xxxxxxxxxxx xxxxxxxxxx xxxx&xxxx;xxxx xxxxxxxxx&xxxx;XXX,&xxxx;xxxxx posuzuje, xxx xxxxxxx o udělení xxxx xxxxxx&xxxx;XX&xxxx;xxxxxxx podmínky xxxx x xxxxxx 4.2.
[Xxxxxxxx x článku 5.3: Xxx xxxxxxxxx xxxxxxxxxxx, xxxxxxx xxxxxxxx xxxxxxxxxxx x xxxxxxxx 4.1 a 4.3 xxxx xxxxx xxxxxxxxx Xxxxxxxxxxxxx organizace xx xxxxxxxxxx xx xxxxxx (xxxxx) KTV.
I xxxx xx Xxxxxxxxxxx xxxxxxxx xxxx xxxx xxxxxx, xx xxxx uznávat xxx dříve xxxxxxx XX xxxxxxxxxxx, xxxx xxxxxxxxx xxxxxxxxxxx, xxxxxx Xxxxxxxxx xxxxxxxxx xx Xxxx xxxx moci xxxxxx novou XX, xxxxxxxx xx bude xxxxxxx. Je xx xxxxxx Xxxxxxxxxxxxxx významných xxxx, xxx xx xxxxxx xxx tento xxxx xxxx xxxxxxx XXX, xxxx xxx xxxxxx xxxxx xxxx xx xxxxxxxxx deleguje xx xxxxx xxxxx. Xxxxx by x xxxxxx případě xxxx xxx xxxxxxxx, aby Xxxxxxxxx xxxxxxxxx se xxxxxx Xxxx xxxx xxxxxxx získat TV xxxxxx a s xxxxx xxxxxxxxx xxxx xxx, než začnou xxxxxxxx.]
x)&xxxx;XXX&xxxx;xx xx měly xxxxxxx xxxxxxx xx xxx (3) xxxxxx xx xxxxxxxxxxx x xxxx a léčbou Sportovců a xxxxxxxx znalostí xxxxxxxx x sportovní zátěžové xxxxxxxx. V xxxxxxxxx, xxx xx xxxxxxxxxx xxxxxxxx xxxxxxxxx (xxxx. x&xxxx;Xxxxxxxxx&xxxx;x postižením, xxx xx xxxxx xxxx xxxxxx xxxx xxxxxxxxx&xxxx;Xxxxxxxxx), xx xxxxxxx jeden (1) x členů KTV měl xxx takové xxxxxxxxxx. Xxxxx (1) x xxxxx, který xx xxxxx, by xxx xxxxxxx xxxx předseda KTV.
b) Aby xxxx zajištěna xxxxxxxxxxx xxxxxxxxxx, xxxx všichni xxxxxxx&xxxx;XXX&xxxx;xxxxxxxx prohlášení x xxxxxxxxx střetu xxxxx x x zachování xxxxxxxxxx xxxxx (vzor xxxxxxxxxx je x xxxxxxxxx xx webových xxxxxxxxx&xxxx;XXXX).
5.4&xxxx;Xxxxx&xxxx;Xxxxxxx antidopingová organizace, Xxxxxxxxxxx federace xxxx&xxxx;Xxxxxxxxxxx xxxxxxxxxx Xxxx&xxxx;xxxx xxxxxxxxx xxxxx postup, xxx xxxxx x xxx&xxxx;XXX&xxxx;x&xxxx;XX, xxxxx je v xxxxxxx x xxxxxxxxx xxxxxx&xxxx;Xxxxxxxxxxxxx standardu. Musí xxxx xxxxxxxxx xxxxxxxxxxx xxxxxx postupu tím, xx (xxxxxxxxx) umístí xxxx xxxxxxxxx xx xxxxx viditelném místě xx xxxxx webových xxxxxxxxx.
5.5&xxxx;Xxxxx&xxxx;Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx, Xxxxxxxxxxx xxxxxxxx xxxx&xxxx;Xxxxxxxxxxx xxxxxxxxxx xxxx&xxxx;xxxx xxxxxxxxxx xxxxxxx oznámení (x xxxxxxxxxx xxxx francouzštině) x všech rozhodnutích xxxxx&xxxx;XXX&xxxx;x xxxxxxx či xxxxxxxxx&xxxx;XX&xxxx;x x xxxxx xxxxxxxxxxxx xxxxxx či xxxxxxxxx xxxxxxx 7X xxxxxx Xxxxxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx XXXXX, a xx co nejdříve, x xxxxxx případě xx dvaceti xxxxx (21) xxx xx xxxxxxx xxxxxxxxxx. Xxxxxxxxxx x xxxxxxxxx&xxxx;XX&xxxx;xxxx xxxxxxxxx xxxxxxxxxx xxxxxx xxx xxxxxxxxx. Ohledně xxxxxxxxx&xxxx;XX&xxxx;xxxx xxxxxxxx xxxxxxxxx xxxxxxxxx (x xxxxxxxxxx xxxx xxxxxxxxxxxxx):
x)&xxxx;xxx xxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxxx xxxxxxx x&xxxx;XX&xxxx;xx xxxxxxx xxxxxxxxx xxxxx xxxxxx 4.1 x vysvětlení xxxxxx xxxx, nebo zda xxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxxx zažádat x&xxxx;XX&xxxx;xx xxxxxxx platností, xxx xx byla xxxxxxx xxxxx článku 4.3 x xxxxxxxxxx důvodů xxxx;
x)&xxxx;xxxxxxxxxx xxxxx nebo xxxxxx, dávkování, frekvenci, xxxxxxxx způsob Podávání, xxxx xxxxxx&xxxx;XX&xxxx;(x dobu xxxxxxxxxx xxxxx, xxxxx xx xxxx) a všechny xxxxx xxxxxxxx stanovené x xxxxxxxxxxx x&xxxx;XX; x
x)&xxxx;xxxxxxxx žádosti x&xxxx;XX&xxxx;(xxxxx xxxx vyplněn elektronicky x XXXXX) x xxxxxxxxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxxxxx, xx podmínky xxxxxx 4.2, xxxxx xxx x tuto TV, xxxx splněny (xxxx xxxxxxxxx xxxxx x xxxxxxxxx xxxxx&xxxx;XXXX,&xxxx;Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx Xxxxxxxxx, Xxxxxxxxxxx xxxxxxxx a Organizátorovi xxxxxxxxxx xxxx, xxxx xxxxxx&xxxx;Xxxx, xxxxx xx&xxxx;Xxxxxxxxx&xxxx;xxxx xxxxxxxxx).
[Xxxxxxxx x článku 5.5: Xxxxx xx používán xxxxxxxx xxxxxxx x XX, xxxx xxx Xxxxxxxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xx jiných xxxxxx, xxx xx xxxxxxxxx xxxx zůstat původní xxxxxxxx xxxx francouzský xxxx x xxxx xxx poskytnut xxxxxxxx xxxx xxxxxxxxxxx překlad xxxxxx.
Xxxx xxx xxxxxxxxxx xxxxx xxxxxxxx xxxxxxx, xxxxxx diagnostických testů, xxxxxxxxxxxxx xxxxxxxx a xxxxxx, xxx xxxxxx xxx xxxxxxxxx do xxxxxxxxxx nebo xxxxxxxxxxxxx. Xx systému XXXXX xxxx musí xxx xxxxxx xxxxxxxxx xxxxxxx xxxxx xxxxxxxxx informací (xxxxxx xxxxxxxxx xxxxxxxxxxxxxx xxxxx) x dostatečnými xxxxxxxxxxx, xxx xxxx xxxxx xxxxx xxxxxxxx xxxxxxxx. Xxxxxxx se xxxxxxxxxx, aby xxxxxx xxxxxxx xxxxxxxxx xxxxx xxxx xxxx xxxxx x xxxxxxxxxxxxxx xxxxxxxxxx xxxxxxxxx, xxx xxxx xxxxx lékařské informace xxxxxxx pochopit a xxxxxxx. Xxxxxxxxxxx/xxxxxxxx xxxxxxxx xxxx xxxxxxxxx xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx nebo XXXX, na vyžádání.]
5.6 Když Národní xxxxxxxxxxxxx organizace udělí Sportovci XX, xxxx xxx xxxxxxx xxxxxxxxx, xx x) xx&xxxx;XX&xxxx;xxxxxx xxxxx na xxxxxxx xxxxxx x x) jestliže xx&xxxx;Xxxxxxxxx&xxxx;xxxxx&xxxx;Xxxxxxxxxx xxxxxxxxxxx xxxxxx&xxxx;xxxx se xxxx xxxxxxxx&xxxx;Xxxxxxxxxxx xxxx, xxxxxx xxxx&xxxx;XX&xxxx;xxx xxxx xxxxx xxxxxx, pokud xxxxxx xxxxxx xxxxxxxxxx Xxxxxxxxxxx xxxxxxxx nebo Organizátorem xxxxxxxx akce v xxxxxxx x xxxxxxx 7.0. Xxx by Národní xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxx xxxxxx&xxxx;Xxxxxxxxx&xxxx;xxxxx, xxx xxxxxxxxx xxxxx x xxxxxxx&xxxx;XX&xxxx;Xxxxxxxxxxx xxxxxxxx xxxx&xxxx;Xxxxxxxxxxxx xxxxxxxx Akce a xxxx xx xxx vést x xxxxxxxxx xx xxxxx xxxxxxx xxxxxxxx&xxxx;XX.
5.7&xxxx;Xxxxx Xxxxxxxxxxx federace xxxx&xxxx;Xxxxxxxxxxx xxxxxxxx Akce musí xxxxx xxxxxxxx (xxxxxxxxx xxx, xx xxx umístí xx dobře viditelném xxxxx na svých xxxxxxxx xxxxxxxxx x xxxxx&xxxx;XXXX), xxxxx jasně xxxxxxxxx (1) xxxxx&xxxx;Xxxxxxxxx, xxxx spadá xxx xxxxxx xxxxxxxxxx, xx xxxx xxxxx x&xxxx;XX&xxxx;x xxx; (2) xxxxx xxxxxxxxxx x&xxxx;XX&xxxx;xxxxxx jinými Antidopingovými xxxxxxxxxxxx&xxxx;xxxxx xxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxxx xxxxxxx, x xxxxxxx s xxxxxxx 7.1 (x); x (3) xxxxx xxxxxxxxxx x&xxxx;XX&xxxx;xxxxxx jinými Antidopingovými xxxxxxxxxxxx&xxxx;xxxx xxxxx xxx xxxxxxxxx, xxx xxxx xxxxxx, x souladu x xxxxxxx 7.1 (x).
5.8&xxxx;Xxxxx&xxxx;Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxx&xxxx;XX Xxxxxxxxx&xxxx;x&xxxx;Xxxxxxxxx&xxxx;xx následně stane Sportovcem xxxxxxxxxxx xxxxxx&xxxx;xxxx xx xxxxxxxx&xxxx;Xxxxxxxxxxx Xxxx,&xxxx;XX&xxxx;xxxxxx xxxxxx, xxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxx xxxxxx xxxx&xxxx;XX&xxxx;x xxxxxxx x článkem 7.0. Xxxxx Xxxxxxxxxxx xxxxxxxx xxxxx&xxxx;XX&xxxx;Xxxxxxxxx x&xxxx;Xxxxxxxxx&xxxx;xxxx xxxxxxx na Mezinárodní Xxxx&xxxx;xxxxxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx Xxxx, xxxxxx&xxxx;XX&xxxx;xxxxxx, xxxxx a xxxxx xxxxxxxxx&xxxx;Xxxxxxxxxxx xxxxxxxxxx Xxxx&xxxx;xxxxxx xxxx&xxxx;XX&xxxx;x xxxxxxx s xxxxxxx 7.0. X xxxx xxxxx, xx xxxxx příslušná Mezinárodní xxxxxxxx xxxx xxxxxxxxx&xxxx;Xxxxxxxxxxx xxxxxxxxxx Xxxx&xxxx;(xxxxx potřeby) xxxxxxx xxxxx tuto TV, xxxxx (xxxx je xxx xxxxxxx xxxxx&xxxx;Xxxxxxxxx&xxxx;xx xxxxxxxxxxx x xxxxxxxx) xxxx&xxxx;XX&xxxx;xxxxx xxx xxxxxxx xxxx xxxxxx u xxxx Mezinárodní xxxxxxxx xx&xxxx;Xxxxxxxxxxxx xxxxxxxxxx Xxxx&xxxx;xxx&xxxx;xxxxxxx,&xxxx;Xxxxxxx,&xxxx;Xxxxxx&xxxx;xx&xxxx;Xxxxxx Xxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx&xxxx;xxxxxxx x xxxx&xxxx;XX.
6.0&xxxx;Xxxxxx při xxxxxxxx žádostí x&xxxx;XX
6.1&xxxx;Xxxxxxxxx, xxxxx potřebuje TV, by x xx xxx xxxxx xx nejdříve. Xxx xxxxx xxxxxxxx xxxxx&xxxx;Xxx Soutěži by xxx&xxxx;Xxxxxxxxx&xxxx;xxxxx x&xxxx;XX&xxxx;xxxxxxx xxxxxx (30) xxx xxxx xxxx&xxxx;Xxxxxxx, xxxxx se nejedná x naléhavou xx xxxxxxxxxx xxxxxxx.
6.2&xxxx;Xxxxxxxxx&xxxx;xx xxx xxxxx x své Národní xxxxxxxxxxxxx xxxxxxxxxx, Mezinárodní xxxxxxxx x/xxxx x&xxxx;Xxxxxxxxxxxx xxxxxxxxxx Akcí (dle xxxx, xxxx subjekt xx xxxxxxxxx) xxxxxx nebo xxxxxx xxxxxxxxx xxxxxxxx xxxxxxx x&xxxx;XX.&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xx xxxx vytvořit formulář xxxxxxx nebo xxxxxx, xxxxx xxxxxx, xxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxxxx, x xxxxxxxxxxx xxx xx xxxxx xxxxxxxx xxxxxxx. Pokud xx xxxxxxx xxxxxxxx xxxxxxx, xxxx xxx xxxxxxx xx xxxxx "Formuláře xxxxxxx x&xxxx;XX" xxxxxxxxx xx xxxxxxxx xxxxxxxxx&xxxx;XXXX. Xxxxx xxxx může xxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxx tak, xxx obsahoval další xxxxxxxxx xx xxxxxxxxx, xxx xxxxx xxxxx xx xxxxxxx xxxxx xxx xxxxxxxxx.
[Xxxxxxxx x xxxxxx 6.2: X xxxxxxxx xxxxxxxxx xxxxxx Xxxxxxxxx vědět, x xxxxx Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx xx xxx xxxxxxx o XX. Xx xxxxxxxx okolností xx xx xxx Xxxxxxxxx poradit x Xxxxxxx xxxxxxxxxxxxxx organizací x xxxx xxxxxxxxx xxxxxxxxxx, xx xxxxxx xxxxxxx (xxxx xx xxxxx je xxxxxx xxxx držitelem licence), xxx xxxxxxx, xxx xxxxx xx oblasti xxxxxxxxxx pro XX xxxx Xxxxxxx antidopingové xxxxxxxxxx xxxxx xxxxxx xxxxxxxx.
Xxxxx tato Xxxxxxx xxxxxxxxxxxxx organizace xxxxxxx xxxxxxxx xxxxxx o XX, xxxxxxx Xxxxxxxxx xxxxxxx xx xxxx xxxxxxxxxx, xxx xx xx Xxxxxxxxx xxxxxxxx x antidopingovými xxxxxxxx Xxxxxxx xxxxxxxxxxxxx organizace xxxx, xx xxxxx xx xxxxxxxx (xxxxx xx xxxx).
Xxxxx Xxxxxxxxx xxxxx xxxxxxx xx xxxxxxxxxx xxx XX xxxx Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx, měl xx xx xxxxxxxx x xxxxxxxxxxxxxxx xxxxxxxx Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx xxxx xxxxx xxxxxxxxx (pokud xx xxxx od xxxxx, xxx xxxxxxx xxxx bydlí).
Sportovci xx xxxxx xxxxxxx na xxxxxxxxxx x xxxx xxxxxxxxx Národních xxxxxxxxxxxxxxx xxxxxxxxxx xx xxxxxxx x xxxxx x xxxxxxx, zda xx xxxx Národní xxxxxxxxxxxxx xxxxxxxxxx pravomoc xxxxxxxxxx x TV. X xxxxxxx, xx xxxxx x výše xxxxxxxxx Xxxxxxxxx xxxxxxxxxxxxxxx organizací xxxxxxxx rozhodovat x XX xxxx, xxxxx xxxxx x Xxxxxxxxxxx xxxxxxxxxxxx xxxxxx, Xxxxxxxxx xx xxx xxx xxxxxxx možnost požádat x XX se xxxxxxx xxxxxxxxx u Xxxxxxxxxxxxx organizace, která xx xxxxxxxxx k Xxxxxxxxx s výsledky. Xxx xxxx souhrnné xxxxxxxx xxxxxxxx x xxxxx "Kde xxxxxxxα" x xxxxxxxx xxxxx xxxxxxxx xxxxxxx XXXX.]
6.3&xxxx;Xxxxxxxxx&xxxx;xxxxx xxxxxxx více xxx xxxxx (1)&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxx&xxxx;x&xxxx;XX&xxxx;xx Xxxxxxx xxxxxx&xxxx;Xxxxxxxx látky nebo Zakázané xxxxxx&xxxx;xxx xxxxxx xxxxxxxxx xxxxxx.&xxxx;Xxxxxxxxx&xxxx;xxxxx xxx xxxxxxxx xxxx xxx jednu (1)&xxxx;XX&xxxx;xxx&xxxx;Xxxxxxx&xxxx;xxxxxx&xxxx;Xxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx&xxxx;xxx xxxxxx zdravotní xxxxxx (x xxxxxxxx xxxxxx xxxx&xxxx;XX&xxxx;xxxxxxx předchozí TV, která xx xxxx být xxxxxxx xxxxxxxxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxx).
6.4&xxxx;Xxxxxxxxx&xxxx;xx xxx xxxxx žádost x&xxxx;XX&xxxx;x příslušné Antidopingové xxxxxxxxxx&xxxx;xxxxxxxxxxxxxxx xxxxxxx&xxxx;XXXXX&xxxx;x/xxxx xxxxx xxxxxxxx xxxxxxx xxxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxx. X žádosti xx xxxxx xxxxxxxx xxxxxx xxxxxxxx, xxxxxx xxxxxxxxxxx xx xxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxx (xxxxxx) (je-li xx xxxxx) x xxxxxxxx xxxxx xxxxxxxxxxxx xxxxxxxxx, xxxxxxxxxxxxx xxxxxxxxx x xxxxxx xxxxxxxxxxxxx xx xxxxxxx. Žádost xxxx xxx xx xxxxxxx místě xxxxxxxxx xxxxxxx.
[Xxxxxxxx k článku 6.4: Xxxxxxxxx xxxxxxxxxx x xxxxxxxxxxx x xxxxxxxxx x xxxxxx xx xxxx xxx x xxxxxxx x xxxxxxxxxxx dokumenty XXXX xxxxxxxxxx xx xxxxxxxx xxxxxxxxx XXXX.]
6.5&xxxx;Xxxxxxxxx&xxxx;xx xx xxx ponechat xxxxxxxxx xxxxx xxxxxxx x&xxxx;XX&xxxx;x xxxxx všech xxxxxxxxx x údajů xxxxxxxx xxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx.
6.6&xxxx;Xxxxxx o TV bude xxxxxxxxx&xxxx;XXX&xxxx;xxxxx x xxxxxxx xxxxxxxx xxxxxxx vyplněné xxxxxxx, xx které xxxx být xxxxxxxxx xxxxxxx relevantní dokumenty. Xxxxxxxxxxx xxxxxx bude xxxxxxx&xxxx;Xxxxxxxxx, xxx xx xxxxxxx x xxxxx xxxxx.
6.7&xxxx;XXX&xxxx;xxxx xxxxxxxxx xx&xxxx;Xxxxxxxxx&xxxx;xxxx xxxx lékaře xxxxxxxx xxxxx xxxxxxxxx, vyšetření xxxx xxxxxx či xxxxx údaje, xxxxx xx jeví xxxx xxxxxxxx xxx posouzení xxxxxxx&xxxx;Xxxxxxxxx; x/xxxx xx xxxx vyžádat další xxxxxxxx xx xxxxxxx xxxxxxxxx, považuje-li xx xx vhodné.
6.8 Jakékoli xxxxxxx xxxxxxx s xxxxxxx xxxxxxx o TV a jejím xxxxxxxxxxx xxx xxxxxxxxx&xxxx;XXX&xxxx;xxxx xxxxxxx&xxxx;Xxxxxxxxxx.
6.9&xxxx;XXX&xxxx;xxxxxxxx, zda xxxxx, xxxx neudělí TV, co xxxxx nejdříve x xxxxxxx (xx. pokud xxxxxxxxxx xxxxxxxxx xxxxxxxxx) xxxxx xx více xxx 21 dnů xx xxxxxxxx xxxxxxxxx xxxxxxx. X xxxxxxx, xx žádost x&xxxx;XX&xxxx;xx xxxxxx v xxxxxxxxxx xxxx xxxx&xxxx;Xxxx,&xxxx;XXX&xxxx;xxxxxx xxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxxx xxxxxxx o TV před xxxxxxxx&xxxx;Xxxx.
6.10&xxxx;Xxxxxxxxxx&xxxx;XXX&xxxx;xxxx xxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxx xxxxxxx x xxxx být x xxxxxxxxx&xxxx;XXXX&xxxx;x xxxxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxxx&xxxx;xxxxxxxxxxxxxxx xxxxxxx&xxxx;XXXXX&xxxx;x xxxxxxx x xxxxxxx 5.5.
6.11&xxxx;Xxxxx&xxxx;XX&xxxx;xxxx xxx určenou xxxx xxxxxx dle xxxxxxxxxx&xxxx;XXX, xxxxxxxx&xxxx;XX&xxxx;xxxxx automaticky xxxxxxxxx xxxx doby. Xxxxx xxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxxxxx x xxxxxx&xxxx;Xxxxxxxx Xxxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxxx xxxxxx&xxxx;xx xxxxxxxx xxxxxxxxx&xxxx;XX, musí xx xxxxx žádost x xxxxx&xxxx;XX&xxxx;xxxx xxxxxxxxx xxxx platnosti TV tak, xxx xxxx xxxxx xxxxxxxxxx x xxxx xxxxxxx x xxxxxxxxxx xxxxxx xxxxx xxxx skončením xxxxxxxxx&xxxx;XX.
[Xxxxxxxx x xxxxxx 6.11: Xxxx xxxxxxxxx xx xxxx xxx xxxxxxxxx xxx dokumentů XXXX "Xxxxxxxx xxxxxxxxx xxx xxxxxxxxxxx o XX".]
6.12&xxxx;XX&xxxx;xxxx xxxxxxx xxxxx xxxx xxxxxxxxx doby xxxxxxxxx v případě, xxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxxx splňovat požadavky xxxx podmínky xxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxx, xxxxx xxxxxxx&xxxx;XX. Xxxxxxx xxxxxxx či xxxxxxxxx&xxxx;XX&xxxx;xxxx být změněno xx xxxxxxx xxxxxxxxxxx&xxxx;XXXX&xxxx;xxxx xxxxxxxx.
6.13&xxxx;Xxxxx xx xxxxxx xx xxxxxxxx xxxx xxxxxxxxx&xxxx;XX&xxxx;xxx xxxxx&xxxx;Xxxxxxxxx xxxxx&xxxx;xx xxxx, co byla TV zrušena xx obnovena, oznámen Pozitivní xxxxxxxxxxx xxxxx,&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx, xxxxx xxxxx xxxxxxxxxxx&xxxx;Xxxxxxxxx xxxxxxxxxxx xxxxx&xxxx;x xxxxxxx x článkem 5.1.1.1&xxxx;Xxxxxxxxxxxxx xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxx x xxxxxxxx, xxxxxxxx, zda xxxxx xxxxxxxx&xxxx;Xxxxxxx Xxxxxxxx látky před xxxxxxxxx doby platnosti, xxxxxxxx xx změnou TV. Xxxxx xxx, xxxx xxxxxx&xxxx;Xxxxxxx&xxxx;(x ani xxxxxxxx xxxxxxxxxx&xxxx;Xxxxxxxx xxxxx&xxxx;xx&xxxx;Xxxxxx Xxxxxxxxx) xxxxxxxxx xxxxxxxxxxxxxxx pravidel.
6.14 V xxxxxxx, že xxxx, xx xx udělena TV, Sportovec požaduje xxxxxxx jiné xxxxxxxxx, xxxxxxxxx, způsob xxxxx xx xxxx xxxxxx&xxxx;Xxxxxxxx Xxxxxxxx látky či Zakázané metody, xxx xxxxx xx xxxxxxx x&xxxx;XX, xxxx xxxxxxxxxxx xxxxxxxxxx&xxxx;Xxxxxxxxxxxxxx organizaci, xxxxx xxxxxxxx, xxx&xxxx;Xxxxxxxxx&xxxx;xxxx xxxxxxx o xxxxx&xxxx;XX. Xxxxx xxxxxxxxxx,&xxxx;Xxxxxxx,&xxxx;Xxxxxx&xxxx;xx&xxxx;Xxxxxxxx&xxxx;xxxxx&xxxx;Xxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx&xxxx;xxxx x xxxxxxx x xxxxxxxxxx, xx xxxxxxx xxxx&xxxx;XX&xxxx;xxxxxxx, xxxxxxxxxx, xx&xxxx;Xxxxxxxxx&xxxx;xx&xxxx;XX, xxxxxxxxx xxxxxxxxxxxx, xx xxxx porušena xxxxxxxxxxxxx xxxxxxxx.
[Xxxxxxxx x xxxxxx 6.14: Uznává xx, xx x xxxxxxxx zdravotních potíží xxxx dávkování xxxxxxx, xxxxxxx x xxxxxx xxxxxx xxxxxxxx xxxxxxxxx xxxxxx xxxx x xxxxxx, xxxx xx xxxxxxxx xxx xxxxxxxxxx xx inzulínu. Tyto xxxxxxxxxxx výkyvy xx xxxx xxx zohledněny x XX. V xxxxxxx xxxxx, xxxxx xxxx v XX xxxxxxxx, xxxx Sportovec xxxxxxxxxxx xxxxxxxxxx Antidopingovou xxxxxxxxxx, xxx xxxxxxx, xxx xx vyžadována xxxx XX.]
7.0&xxxx;Xxxxxx při xxxxxxxx&xxxx;XX
7.1&xxxx;Xxxxxx 4.4&xxxx;Xxxxxx&xxxx;xxxxxxxx, xxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxx&xxxx;XX&xxxx;xxxxxxx jinými Antidopingovými organizacemi, xxxxx xxxxxxx xxxxxxxx xxxxxx 4.2. Pokud xxxx&xxxx;Xxxxxxxxx, xx xxxx xx xxxxxxxx xxxxxxxxx&xxxx;XX&xxxx;xxxxxx Xxxxxxxxxxx xxxxxxxx nebo Organizátora xxxxxxxx Akce, xxx&xxxx;XX&xxxx;xx, xxxxxx xxxxxxx xxxxxx x novou TV u této Xxxxxxxxxxx federace xxxx Xxxxxxxxxxxx xxxxxxxx Xxxx. Xxxxxxx xxxx:
x)&xxxx;Xxxxxxxxxxx xxxxxxxx xxxx&xxxx;Xxxxxxxxxxx xxxxxxxx Xxxx&xxxx;xxxxx xxxxxxxxx xxxxxxxx, xx xxxxxxxxxxx uznávají xxxxxxxxxx x&xxxx;XX&xxxx;xxxxxxx x souladu x xxxxxxx 4.4&xxxx;Xxxxxx&xxxx;(xxxx xxxxxx xxxxxxxxx takových xxxxxxxxxx, např. xxxxxxxxxx xxxxxxx určitými Antidopingovými xxxxxxxxxxxx&xxxx;xxxx xxxxxxxxxx xxxxxxxxxx xx xx konkrétním Xxxxxxxxx xxxxxx), xx předpokladu, xx xxxxxx xxxxxxxxxx x&xxxx;XX&xxxx;xxxx xxxxxxxx x xxxxxxx s článkem 5.5. Xxxxx&xxxx;XX Xxxxxxxxx&xxxx;xxxxx xx kategorie TV, které xxxx automaticky uznávány xxxxx způsobem x xxxx, xxx je TV udělována, xxxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxx podnikat xxxxx xxxxx xxxxx. Xxxxxxx xxxx&xxxx;XX&xxxx;xxxxxxxxxxx uznána, xxxxx xxx xxxxxxxxx další xxxxxxxx xx strany Antidopingové xxxxxxxxxx.
[Xxxxxxxx x xxxxxx 7.1 (a): Xxxxxxxxxxx xxxxxxxx xxxxxxxxxx o XX může zjednodušit xxxxxx xxx Sportovce. Xxxxxxxxxxx xxxxxxxx a Xxxxxxxxxxxx xxxxxxxxxx xxxx xx však xxxx xxxxxxx vybírat xxxxxxxxxxxxx xxxxxxxxxx x/xxxx xxxxx, xxx které xxxxx XX xxxxxxxxxxx xxxxxxx. Xxxxx Mezinárodní xxxxxxxx xxxx Xxxxxxxxxxxx xxxxxxxxxx Xxxx chtějí xxxxxxxxxxx xxxxx xxxxxxxxxx x XX, xxxx by xx svých xxxxxxxx xxxxxxxxx zveřejnit x xxxxxxxxxxxx Xxxxxx Antidopingových xxxxxxxxxx, xxxxxxx rozhodnutí x TV xxxxx xxxxxxxxxxx uznávat, a/nebo Xxxxxx xxxx Zakázaných xxxxx, pro xxxxx xxxxx xxxxxxxxxx o XX xxxxxxxxxxx xxxxxxx.]
x)&xxxx;X xxxxxxx, xx xxxxxx xxxxxxxxxxx uznání xxxxxxxxxx,&xxxx;Xxxxxxxxx&xxxx;xxxx xxxxxx x uznání xxxxxxx&xxxx;XX&xxxx;xxxxxxxxx Xxxxxxxxxxx xxxxxxxx xxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxx Xxxx, x xx prostřednictvím ADAMS, xxxx xxxxx xxxxxxxx xxxxxxxxxxxxxx touto Xxxxxxxxxxx xxxxxxxx xx&xxxx;Xxxxxxxxxxxxx xxxxxxxx Xxxx.
[Xxxxxxxx x článku 7.1 (x): Xxxxxx xx založeno výhradně xx splnění xxxxxxxx xxxxxx 4.2. Xxxxx xxxxxxx xxxx platnosti XX xxxx důvodem x zamítnutí xxxxxx (xxxxx xx netýká xxxxxxx xxxxxxxx článku 4.2). Xxxx xxxxxxxxx XX xx xx xxxxxxxx xxxx xxxxx xxxxxxxxxx WADA s xxxxxx "Xxxxxxxx xxxxxxxxx xxx rozhodování x XX".]
7.2&xxxx;Xxxxxxx žádosti x xxxxxx&xxxx;XX&xxxx;xxxxx xxxxxxx&xxxx;Xxxxxxxxx&xxxx;x xxxxxxxx x opětovnému xxxxxx. Xxxxx xxxx může KTV požadovat xx&xxxx;Xxxxxxxxx&xxxx;xxxx xxxx xxxxxx xxxxxxxxx xxxxx xxxxxxxxx, xxxxxxxxx nebo snímky xx další údaje, xxx xxxxxxxx xx xxxxxxxx pro xxxxxxxxx xxxxxxx Xxxxxxxxx o xxxxxx&xxxx;XX; x/xxxx xx xxxx vyžádat asistenci xxxxxxx lékařských xxxx xxxxxxxxx odborníků, xxxxxxxx-xx xx xx vhodné.
7.3 Za xxxxxxx xxxxxxx, xxxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxxx xxx xxxxxx xxxxxxx x&xxxx;XX&xxxx;x xxxxx doplňování xxxxx požadavků KTV, odpovídá Sportovec.
7.4 KTV rozhodne, xxx xxxx, xxxx xxxxxx&xxxx;XX, xx možná xxxxxxxx, a xxxxxxx (xx. xxxxx xxxxxxxxxx xxxxxxxxx xxxxxxxxx) xx xxxxxxx xxxxx (21) xxx xx obdržení xxxxxxxxx xxxxxxx x xxxxxx. Xxxxx xx xxxxxx xxxxxx x xxxxxxxxx době xxxx xxxxxxx&xxxx;Xxxx,&xxxx;XXX&xxxx;xxxx xxxxxxxx xxxxxxxxx xxxxx, xxx vydala xxx rozhodnutí xxxx xxxxxxxxx&xxxx;Xxxx.
7.5&xxxx;Xxxxxxxxxx XXX xxxx xxxxxxx xxxxxxxx Xxxxxxxxx x xxxx x xxxxxxxxx&xxxx;XXXX&xxxx;x xxxxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxxx&xxxx;xxxxxxxxxxxxxxx&xxxx;XXXXX. Xxxxxxxxxx neuznat TV musí xxxxxxxxx xxxxxxxxxx xxxxxx pro xxxxxxxx.
7.6&xxxx;Xxxxx xx Xxxxxxxxxxx xxxxxxxx xxxxxxxx testovat Sportovce, xxxxx xxxx&xxxx;Xxxxxxxxxx xxxxxxxxxxx xxxxxx, xxxx xxxxx&xxxx;XX&xxxx;xxxxxxxx&xxxx;Xxxxxxx xxxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxx&xxxx;Xxxxxxxxx, xxxxx xxxx vyžadováno, xxx xx&xxxx;Xxxxxxxxx&xxxx;xxxxxxx x uznání TV v xxxxxxx x xxxxxx 5.8 x 7.0, xx. xxxxxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxx xx&xxxx;Xxxxxxxxxxx Xxxx.
8.0&xxxx;Xxxxxxxxxxx rozhodnutí x&xxxx;XX&xxxx;xx xxxxxx&xxxx;XXXX
8.1&xxxx;Xxxxxx 4.4.6&xxxx;Xxxxxx&xxxx;xxxxxxxxx, xx&xxxx;XXXX&xxxx;xxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxxxx rozhodnutí Mezinárodních xxxxxxxx x&xxxx;XX&xxxx;x xx xxxx přezkoumávat xxxxxxxx xxxxx xxxxxxxxxx x&xxxx;XX, xxx xxxxxx x xxxxxx xxxxxxx soulad x xxxxxxxxxx článku 4.1 x 4.2. X xxxxxxxxxxx x xxxxxxxxxx xxxxxx 4.2&xxxx;XXXX&xxxx;xxxxx&xxxx;XXX&xxxx;XXXX. xxxxx xxxxxxx požadavky xxxxxx 5.3 x xxxxxxxxx xxxxxx xxxxxxxx. X xxxxxxxxxxx x xxxxxxxxxx článku 4.1 xx xxxx přezkoumávat WADA (která xx xxxx xxx xxxxx uvážení xxxxxxxxxxx xx členem KTV WADA).
8.2 Každá xxxxxx x xxxxxxxxxxx musí xxx xxxxxx xxxxxxxxxx&xxxx;XXXX&xxxx;xxxxxxxx xxxxxx x xxxx xxx xxxxxxxx xxxxxx x xxxxxxxxx příslušného xxxxxxxx xx žádost xxxxxxxxxxx&xxxx;XXXX, x xxxx xxxx xxxxx xxxxx xxxxx xxxxxxxxxxxxxxx x xxxxxx 6.4 (xxxx x xxxxxxx xxxxxxxxxxx xxxxxxxxx&xxxx;XX&xxxx;xxxxxxx xxxxx, které Sportovec předložil x souvislosti x xxxxxxx xxxxxxx o TV). Xxxx být vytvořena xxxxx žádosti xxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxx, xxxxx xxxxxxxxxx xx xxxxxxxxx přezkoumání, x xxx&xxxx;Xxxxxxxxx&xxxx;(xxxxx xxxxxx x xxxx xxxxxxxxxxx).
8.3&xxxx;X xxxxxxx xxxxxxx x xxxxxxxxxxx xxxxxxxxxx x&xxxx;XX, xxxxx&xxxx;XXXX&xxxx;xxxx xxxxxxx přezkoumávat, WADA co xxxxxxxx po xxxxxxxx xxxxxxx xxxxxxxxx Xxxxxxxxx, xxx dané xxxxxxxxxx x&xxxx;XX&xxxx;xxxxxxxxx, xx nikoli. Xxxxxxxx xxxxxxxxxx&xxxx;XXXX&xxxx;xxxxxxxxxxxxxx xxxxxxxxxx x&xxxx;XX&xxxx;xx xxxxxxx x xxxxx xx xxxxx xxxx xxxxxxx. Xxxxxxx xxxxx xxxxxxxxxx o TV se xxxxx xxx odvolat, xxx xx stanoveno x článku 4.4.7&xxxx;Xxxxxx.
8.4&xxxx;X xxxxxxx žádosti x xxxxxxxxxxx rozhodnutí x&xxxx;XX, xxxxxxxxx Xxxxxxxxxxx federací, xxxxx xx&xxxx;XXXX&xxxx;xxxxxxx xxxxxxxxxxxx, xxxx&xxxx;XXXX&xxxx;xxxxxxx xxxxxx rozhodnutí xxxx Xxxxxxxxxxx xxxxxxxx (x) x xxxxxx xxxxxxxxx (například, pokud xxxxxx x xxxxxxxxxx xxxxx xxxxxxxxx xxxxxx); x/xxxx xx (b) x xxxxxxxxxx zvážení Xxxxxxxxxxx xxxxxxxx (například, xxxxx&xxxx;XX&xxxx;xxxx xxxxxxxxx xxxxx xxxxx chybějícím xxxxxxxxx xxxxxx xxxx xxxxx xxxxxxxxxx xxxxxx, xxxxxxxxxxx x xxxxxxxxx splnění xxxxxxxx xxxxxx 4.2).
[Xxxxxxxx x xxxxxx 8.4: Xxxxx Mezinárodní federace xxxxxxx xxxxx XX xxxxxxxx Xxxxxxx antidopingovou xxxxxxxxxx xxxxx xxxxx xxxxxxxxxx xxxxxxxxx xxxxxx xxxx xxxxx xxxxxxxxxx xxxxxx, xxxxxxxxxxx x xxxxxxxxx xxxxxxx xxxxxxxx xxxxxx 4.2, xxxxxxxxxx xx xxxxxx být xxxxxxxxxx XXXX. Místo xxxx xx xxx xxx xxxx xxxxxxx x xxxxx xxxxxxx Xxxxxxxxxxx federací.]
8.5 V xxxxxxx, xx je žádost x xxxxxxxxxxx postoupena KTV WADA. KTV WADA si xxxx xxxxxxx další xxxxxxxxx od Antidopingové organizace a/nebo xx&xxxx;Xxxxxxxxx, xxxxxx dalších xxxxxx popsaných x xxxxxx 6.7, x/xxxx xx xxxx obstarat xxxxxxxxx dalších xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxx, xxxxxxxx-xx xx xx xxxxxx.
8.6&xxxx;XXXX&xxxx;xxxxx jakékoli xxxxxxx&xxxx;XX, xxxxx nesplňuje podmínky xxxxxx 4.1 x 4.2 (xxx situace). X případě, že xxxxxxx&xxxx;XX&xxxx;xxxx&xxxx;XX&xxxx;x budoucí xxxxxxxxx (xx xxxxxx od TV se xxxxxxx platností), xxxxxx xxxxxx xxxxxxx xxxxxxxxx xxxx xxxxxxx&xxxx;XXXX&xxxx;(xxx nebude xxxxx xxx datum xxxxxxxx&xxxx;Xxxxxxxxx&xxxx;xx strany WADA). Zrušení xxxxxxx xxxxxx a xxxxxxxx&xxxx;Xxxxxxxxx&xxxx;xxxx xxxxx xxxxxxxxx xxxxxxx&xxxx;Xxxxxxxxx. X xxxxxxx, xx zrušená TV byla TV se zpětnou xxxxxxxxx, xx xxxx xxxxxxx také zpětnou xxxxxxxx.
8.7&xxxx;XXXX&xxxx;xxxxx xxxxxxxx xxxxxxxxx&xxxx;XX&xxxx;x xxxxxxx, xxx xxxxxx x&xxxx;XX&xxxx;xxxxxxx xxxxxxxx xxxxxx 4.1 x 4.2 (xxx xxxxxxx), xx. xxxxx&xxxx;XX.
8.8&xxxx;Xxxxx&xxxx;XXXX&xxxx;xxxxxxxxxxx xxxxxxxxxx Xxxxxxxxxxx xxxxxxxx, které xx xxxx xxxxxxx x xxxxxxx x článkem 4.4.3&xxxx;Xxxxxx&xxxx;(xx. povinné přezkoumání), xxxx xxxxxxxxx, xxx xxxxxxxx&xxxx;Xxxxxxxxxxxxx organizace, xxxxx "xxxxxxxx" xxx xxxxxxxxxxx (xx. Antidopingová organizace, xxxxx stanovisko xxxx xxxxxxxxx), (x) xxxxxxxxxx xxxxxxxx za xxxxxx xxxxxxx xxxxxx, která xxxxxxxxxx xxxxxxxxxx&xxxx;XXXX&xxxx;(xx-xx xx xxxxxxxxxx); x/xxxx (x) xxx zaplatila xxxxxxx xxxxxxx&xxxx;XXXX&xxxx;x xxxxxxxxxxx s xxxxx xxxxxxxxxxxx xx xxxx, xxxxx xxx xxxx xxxxxxx poplatkem xx podání xxxxxxx.
8.9&xxxx;X xxxxxxx, xx&xxxx;XXXX&xxxx;xxxxx xxxxxxxxxx x&xxxx;XX, které xx&xxxx;XXXX&xxxx;xxxxxxxx xxxxx svého xxxxxxx xxxxxxxxxx,&xxxx;XXXX&xxxx;xxxx xxxxxxxxx, xxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx, která přijala xxxxxxxxxx, xxxxxxxxx xxxxxxx xxxxxxx&xxxx;XXXX&xxxx;x xxxxxxxxxxx x xxxxx xxxxxxxxxxxx.
8.10&xxxx;Xx-xx xx xxxxxxxxxx,&xxxx;XXXX&xxxx;xxxxx xxxxxxxxxx rozhodnutí KTV WADA neprodleně Sportovci a xxxx&xxxx;Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx&xxxx;x Xxxxxxxxxxx xxxxxxxx (x, xx-xx xx xxxxxxxxxx,&xxxx;Xxxxxxxxxxxxxx xxxxxxxx Xxxx).
9.0&xxxx;Xxxxxxxxx informací
9.1 Zpracování Xxxxxxxx&xxxx;xxxxx během xxxxxxx&xxxx;XX Xxxxxxxxxxxxxxx organizacemi musí xxx x souladu s Mezinárodním xxxxxxxxxx&xxxx;xx ochranu xxxxxxxx x xxxxxxxx xxxxx.&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxx, xxx xxxx xxxxxx xxxxxxxxx xxxx xxxxxx xxxxxx xxx xxxxxx&xxxx;Xxxxxxxxxx&xxxx;x souladu s Mezinárodním xxxxxxxxxx&xxxx;xx ochranu soukromí x xxxxxxxx údajů x xxxxxxxx zákony.
9.2 Antidopingové xxxxxxxxxx&xxxx;x souladu s xxxxxxx 7.1&xxxx;Xxxxxxxxxxxxx standardu na xxxxxxx xxxxxxxx a xxxxxxxx xxxxx xxxxxxx xxxxx&xxxx;Xxxxxxxxxx&xxxx;xxxxxxxxxxx informace x xxxxxxxxxxx x xxxxxxx&xxxx;Xxxxxxxxx&xxxx;x xxxxxxx xxxx xxxxxx&xxxx;XX:
x)&xxxx;Xxxxxxx xxxxxxxxx xxxxxxxx xx xxxxxxx budou předány xxxxxx xxxxx&xxxx;XXX&xxxx;x oprávněním xxxxx xxxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxx&xxxx;xxxxxxxxxxxx xxxx a xxxxx xxxxxxx dalším xxxxxxxxxx xxxxxxxxx nebo vědeckým xxxxxxxxxx x xxxx xxxxxxxxx xxxxxxxxxxx (xxxxxx xxxxxxxxxx&xxxx;XXXX) xxxxxxxxx xx xxxxxx, xxxxxxxxxxxxx xxxx xxxxxxxx xxxxxxx x&xxxx;XX;
x)&xxxx;Xxxxxxxxx&xxxx;xxxx xxxxxxx xxxxx xxxxxx (xxx xxxxxx), xxx xx xxxxxxxx xxxxxxx xxxxxxxxx&xxxx;XXX&xxxx;xxxxxxxx zdravotní informace, xxxxx považuje příslušná KTV za xxxxxxxx xxx xxxxxxxxx x xxxxxxxxxx x xxxxxxx&xxxx;Xxxxxxxxx; x
x)&xxxx;Xxxxxxxxxx x xxxxxxx bude xxxxxxxxxxxx xxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxxx&xxxx;x xxxxxxxxxx xxxxxxxx&xxxx;Xxxxxxxxx&xxxx;x/xxxx xxxxxx xxx&xxxx;Xxxxxxxxx x xxxxxxxx&xxxx;x xxxxxxxxx xxxxxxxxxx xx x xxxxxx&xxxx;Xxxxxxxxx.
[Xxxxxxxx k článku 9.2: X případech, xxx xx Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxx o xxxxxxx Sportovce xx Xxxxxxxxxxx Xxxxxxxx xxxxx x xxxxxxxxxxx x xxxxxxxx XX, Xxxxxxxxx xxxxxxxx x udělení xxxx uznání XX xxxxxxxx xxxxxxx a xxxxxxxx xxxxxxx s xxxx xxxxxxxx.]
9.3&xxxx;Xxxxxx o TV bude xxxxxx v xxxxxxx x principy xxxxxx xxxxxxxx mlčenlivosti. Xxxxxxx xxxxx xxxxxxxxxxx&xxxx;XXX, nezávislí xxxxxxxxx x xxxxxxxxx xxxxxxxxxx&xxxx;Xxxxxxxxxxxxx organizace budou xxx xxxxx svých xxxxxxxxxx xxxxxxxxxx xx xxxxxxx xxxxxxxxxx xxxxxxx xxxxxxxxxxx x xxxxxxxx xxxxxxxxx xxxxxxx x xxxxxxx xxxxxxxxx xxxxxxxxx. Xxxxx xxxxxxxxxx xxxxxxxxxxx zejména x:
x)&xxxx;xxxxxxxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxx&xxxx;Xxxxxxxxxx&xxxx;x lékařem (xxxxxx), xxxxx se péče x&xxxx;Xxxxxxxxx&xxxx;xxxx; a
b) veškerých podrobnostech xxxxxxx, včetně xxxxx xxxxxx (lékařů) zapojených xx celé záležitosti.
9.4 Pokud xx&xxxx;Xxxxxxxxx&xxxx;xxxxx odvolat xxxxx&xxxx;XXX&xxxx;xx xxxxxxxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxx xxxxxx, xxxxxx xxxx xxxxxxxx xxxxx xxxxxx písemnou xxxxxx; xx podmínky, xx xxxx důsledek xxxxxx odvolání xxxx xxxxxx&xxxx;Xxxxxxxxx&xxxx;x&xxxx;XX&xxxx;xxxx x xxxxxx xxx existující TV považována xx xxxxxxxx, aniž xx xxxx xxxxxxx schválení/uznání.
9.5 Antidopingové xxxxxxxxxx&xxxx;xxxxx xxxxxxxx xxxxx xxxxxxxxx poskytnuté Sportovcem v xxxxxxxxxxx x xxxxxxx x&xxxx;XX&xxxx;x xxxxxxxxxxx xxxxxxx x x xxxxxxxxxxx x xxxxxxx xxxxxxxxxxxxx a xxxxxxxx xxx xxxxxxxx xxxxxxxxxxxxxxx pravidel.
PŘÍLOHA 1: XXXXXXXXX XXXXXXX DLE XXXXXX 4.4 KODEXU
1. Postup xxx xxxxxxx x&xxxx;XX&xxxx;x xxxxxxx, že Sportovec není Sportovcem mezinárodní xxxxxx, xxxx xxxxxxxxx&xxxx;XX
2.&xxxx;Xxxxxx při xxxxxxx x&xxxx;XX&xxxx;x xxxxxxx, xxx je Sportovec Sportovcem mezinárodní xxxxxx&xxxx;(x xxxxxxx tedy xxxxxxxxxx xx&xxxx;XX&xxxx;Xxxxxxxxxxx federace), xxxx xxxxxxxxx TV
3. Sportovec se xxxxxxx&xxxx;Xxxx, pro xxxxxx xx&xxxx;Xxxxxxxxxxx xxxxxxxx xxxx&xxxx;(XXX) xxxxxxx požadavky
Informace
Právní xxxxxxx x. 32/2023 Xx. x. x. xxxxx xxxxxxxxx xxxx 22.8.2023.
Xxxxxx předpis x. 32/2023 Xx. x. x. byl xxxxxx xxxxxxx xxxxxxxxx č. 19/2025 Sb. s xxxxxxxxx xx 28.1.2025.
Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx uvedeného právního xxxxxxxx.
1) Mezinárodní xxxxxx xxxxx dopingu xx xxxxxx, xxxxxxx dne 19. října 2005 x Xxxxxx, xxxx xxxxxxxxx x anglickém xxxxx x x xxxxxxxxx do xxxxxxx xxxxxx xxx č. 58/2007 Sb. m. s.
Nové xxxxx překladu Xxxxxx xx xxxxxxx xxxxxx xxxx xxxxxxxxx xxx č. 46/2008 Sb. m. s.
2) Příloha X xxx rok 2022 xxxxxx xxxxxxxxx ve Xxxxxx xxxxxxxxxxxxx smluv, xxxxx xxx 22. xxxxxx 2023 xxxxxxx xxxxxxxxx xxx Xxxxxx xxxxxxxxx.
3) Příloha I xxx xxx 2018 xxxx xxxxxxxxx xxx č. 36/2019 Sb. m. s.
4) Příloha XX xxx xxx 2016 xxxx xxxxxxxxx xxx č. 26/2017 Sb. m. s.